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The marc is a seasonal breeder, with the typical ovulatory period for mares in the
Northern Hemisphere being between mid-April and mid-September. The estrous cycle is
approximately 22 days in length, while estrus usually lasts 3 to 7 days. Most often, one
large graafian follicle is selected to continue its growth becoming a dominant follicle,
while the remaining large antral follicles undergo atresia. The ovulatory follicle in the
mare can range from 35 to 55 rom in diameter, with ovulation generally occurring 24 to
48 h before the end of estrus. In cultured granulosa and thecal cells, IGF-I has dramatic
stimulatory effects on steroidogenesis and mitogenesis (Adashi et aI., 1985; Cara and
Rosenfield, 1988; Hammond et aI., 1988b). As follicle size increases, concentrations of
IGF-I in follicular fluid increase (Hammond et aI., 1988a; Spicer et aI., 1988). Spicer et
aI., (1991) observed a significant correlation between follicular diameter and IGF-I
concentrations in mares. Dramatic changes in steroidogenesis and levels of in IGFBP
occur during the final growth of ovulatory follicles as well as during follicular atresia in
the mare (Gerard and Monget, 1998). These changes in IGFs and IGFBPs could be
important in follicular development, ovulation and (or) atresia (Spicer and Echternkamp,
1995). There may be variation in species-specific mechanisms related to IGF or IGFBP
that regulates follicular development. More information is needed to help understand the
physiological modulators that affect follicular development and maturation in the mare.
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Therefore, the present study evaluated changes in FF steroid and IGFBP levels as





The mare has a seasonally polyestrous type of estrous cycle, which means that she
is receptive to the stallion and ovulates during certain times of the year (Ginther, 1974).
Follicular activity is suppressed in the months of short day length but as day length
increases, the number and size of follicles will increase (Ginther, 1979). The mare's
seasonal changes are divided into two categories, cyclic and anestrus, with a spring and
fall transition period between them. Typical ovulatory period for mares in the Northern
hemisphere is between mid-April and mid-September. The mare will show behavioral
signs of sexual receptivity; such as interest in the stallion, winking of her vulva and
frequent urination; and develop follicles that will ovulate. However, there are some
mares that will exhibit signs of sexual receptivity throughout the year (Ginther, 1979).
The estrous cycle, which is approximately 22 days in length, is divided into two
physiological stages, estrus and diestrus. Estrus, which usually lasts 3 to 7 days, is when
a mare expresses signs of standing heat and final follicular maturation and ovulation
occur. Serum progestin concentrations need to be less than 1 ng/rnl before estrus will
occur in mares (Stabenfeldt et aI., 1972). Diestrus, which typically lasts for 15 to 19
Jays, is the time when the mare is un-receptive to the stallion. Ovulation will generally
3
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occur 24 to 48 h prior to the end of estrus. On the 5th day of estrus, ovulation occurs, and
within 24 h there is an increase in plasma progestins concentration (Stabenfeldt et aI.,
1972).
Ovarian Structures
In mares, the ovary is much larger on a body weight basis than other farm species
(Ginther, 1992). The ovary is kidney shaped and has what is called an ovulation fossa.
The only area that ovulation can occur is at the ovulation fossa. What makes the mare
unique is that the medulla and cortex are inversed from that of other species. The cortex
is on the inside and the thick, connective layer of medulla covers the surface of the ovary
with the exception of the ovulation fossa. The ovulatory follicle in the mare can range
from 35 to 55 rom in size; a possible reason for this large size is that the follicle must
grow towards the ovulation fossa to ovulate. The average diameter of the preovulatory
follicle on the day before ovulation was 44 mm (Ginther et aI., 1989). The right ovary is
often attached 15 cm behind the right kidney, and the left ovary is usually further back
than the right (Sisson and Grossman, 1953). Ovarian weight during the estrous cycle
increases from a low when a mature corpus luteum is present to a high when follicles are
fully grown at estrus, and ovarian weight will then decrease following ovulation (Wesson
and Ginther, 1981).
The ovary has a gametogenic and an endocrine role. There are two prim.:ipal
ovarian components, the follicles and corpus luteum. The follicles are important for the
production of the ova and synthesis of estrogens, while the corpus luteum is responsible
for the production of progestins. Follicles grow and secrete estrogens about every 10
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days in mares with cyclic ovarian activity (Van Rensburg and van Niekerk, 1968; Belin
et aI., 2000).
Follicular Growth
At anyone given time in the mares' ovary, there are several follicles of varying
size and stages of growth. Folliculogenesis is the process of ovarian follicles developing
from primordial to primary, to secondary and then finally antral follicles (Senger, 1997).
Primordial follicles are the smallest and most immature structures in the ovay. The
primordial follicle develops into the primary follicle. Primary follicles have a single
layer of cuboidal follicular cells surrounding the primary oocyte which will start to
increase in diameter as follicular growth occurs. This primary follicle either degenerates
or continues its growth into a secondary follicle. Secondary follicles have two or more
layers of follicular cells around the oocyte. An antral follicle, also known as a tertiary
follicle, has an antrum filled with follicular fluid. The enlarged oocyte, which is now
enclosed in the acellular zona pellucida, is attached to the inner lining, the membrana
granulosa, of the follicle.
Tertiary follicles have three cell layers: the theca extema, theca intema, and
granulosa cell layer. The theca extema consists of loose connective tissue that supports
the follicle. The theca intema is below the theca externa, these cells synthesize
androgens under the influence of LH (Senger, 1997). Granulosa cells possess receptors
to FSH and LH (Fay and Douglas, 19X7) and synthesize estrogen, inhibin and are bathed
in follicular fluid (Senger, 1997). In the mare, antral follicles are usually grouped by
size. Small, medium and large classifications consist of follicles measuring less than 10
6
mm, 10 to 20 mm and greater than 20 mm in diameter, respectively (Senger, 1997). In
the mare, these preovulatory graafian follicles range in size from 35 to 55 mm.
The dominant follicle has been detected at emergence (6 mm) close to 1 day
earlier than the subordinate follicle. Also, on the day of its emergence, the future
dominant follicle was larger than the future subordinate follicle (Gastal et aI., 1997).
This future dominant follicle will continue to grow to become the ovulatory follicle while
the subordinate follicle will regress and undergo atresia. It has been observed that
ovulation occurs about 7 days after the initiation of corpus luteum regression, while in
some instances mares ovulated during the luteal phase of the cycle or while the corpus
luteum was still regressing (Stabcnfeldt et aI., 1972). Several studies have indicated a
greater frequency of ovulation from the left ovary of maiden mares, but after their first
pregnancy, the asymmetry is lost (Ginther, 1979). Throughout the ovulatory cycle,
significant changes in diameter of largest follicle and second largest subordinate follicle
and numbers of follicles 2 to 5 mm, 16 to 20 mm and> 20 mm occur (Ginther and
Pierson, 1989). The number of large follicles increases from January to a peak in April
and then decreases from May through July, after this there is another peak in August, and
then another decline (Wesson and Ginther, 1981).
Once the dominant follicle ovulates, a corpus hemorrhagicum fills the follicular
cavity until a corpus luteum forms and becomes functional, which occurs within 5 days
of ovulation. The corpus luteum is a structure that, unlike most species, cannot be felt via
rectal palpation because of the layer inversion of the mares' ovary. The corpus luteum
produces progesterone and aids in the maintenance of pregnancy until the placenta takes
over. The average life span of the corpus luteum during the estrous cycle is 12 days (Van
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Rensburg and van Niekerk, 1968). The following section will discuss the selection
process that follicles undergo to become a dominant follicle.
Follicle Selection
Gonadotropins (LH and FSH) and growth factors regulate selection and
maturation of dominant ovarian follicles (Hammond et aI., 1991; Adashi 1994; Monniaux
et aI., 1997). In 1975, it was suggested that the mare expresses two waves of follicular
activity during the estrous cycle (Evans and Irvine, 1975). Others proposed that only a
single major follicular wave during the equine estrous cycle existed based on transrectal
palpation (Ginther, 1979). With the advent of ultrasonography, Ginther (1990a) found
that follicular waves (anovulatory and ovulatory) seemed similar to follicular waves in
cattle except that follicles in the mare were much larger. Ultrasonic monitoring of
individual ovarian follicles in heifers has indicated that there are 2 (Ginther and Pierson,
1988; Ginther et al., 1989) or 3 (Savio et aI., 1988; Sirois and Fortune, 1988) waves of
follicular activity during most estrous cycles. Breed differences in follicular wave
patterns during the estrous cycle have been found in mares (for review see Ginther, 1992)
and in cattle (Alvarez et aI., 2000). Usually one major wave develops in late diestrus and
culminates in the ovulation during estrus in breeds such as quarter horses and ponies. In
other breeds such as thoroughbreds, there is a secondary wave, which develops in early
diestrus, and like in cattle, may be anovulatory or ovulatory. Recruitment, selection,
dominance and atresia are all segments of the dynamics of antral follicles. Recruitment is
the stage of antral follicle development in which a group of small follicles begin to
develop and produce estradiol. Some of these recruited follicles will undergo atresia.
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The follicles that do not undergo atresia have been "selected". In cattle and humans,
these follicles will continue their growth and become follicles that produce increasing
amounts of estrogen and inhibin. One of these follicles will become the "dominant"
follicle that inhibits growth of the other antral follicles and causes them to undergo
atresia. In most domestic large animals, recruited follicles will have high follicular fluid
content of FSH, low LH and no inhibin (Senger, 1997). Selected follicles exhibit
moderate levels of FSH, moderate LH and low inhibin (Senger, 1997). The dominant
follicle has low FSH, high LH and high inhibin (Senger, 1997). Goudet et aI., (1999)
found in the mare that the amount of a-inhibin was lower in 5 to 9 mm follicles than in
larger ones. Bergfelt et aI., (1991) and Roser et aI., (1994) reported a reciprocal
relationship between circulating concentrations of inhibin and FSH during the estrous
cycle of the mare.
The mechanism involved in the selection of the dominant follicle in monovular
species is under intense investigation and is not clearly understood, although estradiol has
been suggested as a facilitator of deviation in cattle (Ginther et aI., 1996). In the mare,
the follicular wave begins with 6 mm follicles during mid-diestrus and these follicles
continue to grow similarly until the largest follicle reaches about 23 mm (Gastal et al.,
1997). This follicle has been selected to deviate; selection is not complete until deviation
has occurred. Deviation is where the growth rates between one follicle and the others
differ (Gastal et aI., 1999b). Gastal et al., (1997) found that the future dominant follicle
emerged one day earlier than did the future subordinate follicle, growth rates did not
differ, and that at the beginning of deviation the future dominant follicle was 3 mm larger
than the future subordinate follicle. Gastal et aI., (1999b) also found that there was a
j
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difference in intrafollicular estradiol concentrations between the two follicles before the
difference in diameter and that there is an increase in systemic estradiol the day before
the detection of follicle deviation. An increase in the number ofLH receptors in
granulosa and thecal cells in the dominant follicle has been proposed as a major feature in
the process of follicle selection and dominance at least in cattle (Xu Z et aI., 1995;
Bodensteiner et aI., 1996; Stewart et aI., 1996; Evans and Fortune, 1997;). Also in cattle,
estradiol may function as the mechanism of deviation by inhibiting systemic FSH
concentrations and by intrafollicu1ar facilitation ofLH responsiveness of the larger
follicle (Ginther et aI., 1996). Ginther et aI., (1999) found that systemic FSH
concentrations were decreased for 10 h after the time of deviation in cattle. The
continued growth of the dominant follicle appears to be dependent on LH at least in cattle
(Ginther et aI., 1996; Gong et aI., 1996). Gastal et aI., (2000) found in pony mares that
systemic LH concentrations increased after Day 14 which was similar to reports in
mature mares (Gastal et aI., 1997; Gastal et aI., 1999a) and in cattle (Ginther et aI., 1998),
and that this increase in LH concentrations preceded deviation. [t has been suggested that
LH does not playa role in the initiation of deviation, but is involved in subsequent
growth of the dominant follicle in the mare (Gastal et aI., 2000) and cow (Ginther et al.,
1998). Follicular dominance will he reviewed in the following paragraphs.
Follicle Dominance
The dominant follicle of each wave causes atresia of the subordinate follicles and
blocks the emergence of the second wave until the dominant follicle approaches
ovulation. The next wave can contribute to the regression of the dominant follicle of the
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previous wave. Inhibin and estrogen may be the suppressing factors (Ginther et a1.,
1996). In the mare, Gastal et a1., (1999a) found that if the larger follicle is removed at the
time of deviation, the smaller follicle is capable of becoming the dominant follicle. Large
equine follicles, > 20 mm, can cause a decrease in FSH concentration (Gastal et al..
I999a) and as mentioned have been postulated to playa role in follicle deviation in the
cattle (Ginther et a1., 1996). Because ablation of the larger follicle increased mean LH
concentrations, large follicles of the mare may produce a substance that depresses LH
concentrations (Gastal et a!., 1999a). Ovarian honnone secretion and follicle
development, without alteration of peripheral concentrations ofFSH, are inhibited when
sheep (Campbell et a1., 1991) and cattle (Law et a!., 1992) are treated with inhibin-free
ovine or bovine follicular fluid, suggesting that factors other than FSH are involved in
follicular development.
The levels ofIGF-I and IGFBP-3 found in follicular fluid are similar in dominant
and subordinate follicles (Stewart et a1., 1996; de la Sota et aI., 1996; Funston et aI.,
1996). However, follicular fluid IGFBP-2, -4, and -5 levels are decreased in dominant
follicles of cattle (Stewart et a1., 1996; de la Sota et aI., 1996; Funston et aI., 1996). By
regulating the bioavailability of IGF-I in the follicle, IGFBPs may playa role in follicular
dominance (Stewart et al., 1996). An increase in the number of thecal LH/hCG binding
sites along with a decreased amount of IGFBP activity in early dominant follicles was
observed in cycling dairy cows; IGF-I may mediate the increase in thecal LH receptors
(Stewart et a!., 1995; Stewart et a!., 1996). The stimulatory actions ofIGF-I may be
blocked by an increase in IGFBPs in the late dominant foHicle and may lead to atresia
(Stewart et a!., 1996; Spicer et aI., 1997). Because a decrease in IGFBP-2 mRNA occurs
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during growth of large antral follicles (Howard and Ford, 1992; Samaras et a1.,
1993;Yuan et a1., 1996), changes in local production oflGFBPs likely account for
changes in IGFBP levels in follicular fluid. However, IGFBP proteases may also be
involved. These topics wilJ be addressed in more detail in a later section.
Growth and Development of the CL
A corpus luteum (CL) is formed from the remaining cells of the ovulated follicle.
During the estrous cycle of the mare, the CL occasionally will have prolonged
maintenance (Ginther, 1990b), occurring more often at the end of the ovulatory season
(Weedman et aI., 1993). As mentioned earlier, the average CL lifespan is about 12 days
(Stabenfeldt et aI., 1972). The primary function of the CL is the synthesis and secretion of
progesterone. Short (1962) found that large amounts of progesterone, 200.-
hydroxypregn-4-en-3-one, a small quantity of 17a.-hydroxyprogesterone, and no C 18 or
C 19 steroids were contained in luteal tissue of the mare. There appears to be a direct and
indirect regulation of progesterone secretion by gonadotropins (Kelley et aI., 1988).
Peripheral plasma levels ofprogestins are low during the follicular phase, increase within
24 h of ovulation, are increased during the luteal phase, and decline with CL regression
(Stabenfeldt et aI., 1972). The cyclic progestin levels in the mare (Stabenfeldt et aI.,
1972) closely resemble those of the cow (Stabenfeldt et aI., 1969b) and sow (Stabenfeldt
et aI., 1969a).
There are two distinct steroidogenic cell types known as the small and large luteal
cells which are found in the CL of several species (Ursely and Leymari, 1979; Fitz et aI.,
1982; Hoyer et aI., 1984,1986) including the mare (Kelley et aI., 1988; Watson and
-
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Sertich, 1990). The CL is composed oflarge luteal cells, small luteal cells, a few spindle-
shaped endothelial cells, red blood cells, and a small number ofleucocytes (Watson and
Sterich, 1990). Harrison (1946) thought that the CL in the mare was derived from
granulosa cells. Data indicate that large luteal cells of the early CL in cattle, originate
from granulosa cells while small luteal cells originate from theca cells (Alila and Hansel,
1984). There are very few large cells present early in the estrous cycle, but the number
increases to a peak on Day 12 when they comprise 45% of the steroidogenic cells in ewes
(Schwall et aI., 1986). Granulosa derived large luteal cells disappear during early
pregnancy while cells of thecal origin persist throughout pregnancy in cattle (Alila and
Hansel, 1984). In early, mid- and late diestrus, luteal cells from the CL release
prostaglandins; these concentrations decrease as the age of the CL increases (Watson and
Sterich, 1990). Large luteal cells are thought to secrete high basal amounts of
progesterone, are unresponsive to LH and derived from granulosa cells, while small luteal
cells have low basal secretion of progesterone, but respond to LH with a dramatic
increase in steroid secretion, and are thought to be derived from thecal cells (Koos and
Hansel, 1981; Fitz et aI., 1982). Large and small cells are interspersed in ruminants,
while in the mare the small cells lie between the large cells (Broadley et aI., 1994). It
was suggested that in the mare CL, large cells bind LH (Broadley et aI., 1994).
The CL of the mare produces estrogen if there is an adequate amount of androgen
substrate available (Watson and Thomson, 1996). Previously it was thought that the CL
of the mare, like that of the ewe and cow, does not produce estrogen (Short, 1964;
Mahajan and Samuels, 1974). However, estradiol was detected in the mid-luteal CL of
the mare (YoungLai, 1971) thus, being similar to primates (Stouffer et aI., 1980). The
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equine CL may be involved in estrogen secretion as observed from the CL of non-
pregnant and pregnant mares (Montavon et aI., 1990; Stabenfeldt et aI., 1990). Recently,
Rodger et a1., (1998) reported that P450C17, the enzyme needed for synthesis of
cstradiol-17~,is not found in the CL of the non-pregnant mare. Further studies are
needed to clarify the role of the CL in estradiol secretion in the mare.
PGF2a is known to playa part in luteolysis at the end of diestrus in mares and
other domestic species. In most species PGFI is the predominant prostaglandin released
by the CL, however in the mare, PGE2 has been found to be the predominant
prostaglandin (Watson and Sertich, 1990). The mare is more sensitive to prostaglandins
than the cow and ewe because the lungs of the mare can only metabolize 30% of the
PGF2a in a single passage. Watson and Sertich (1990) found that luteal cells from the
CL of the mare released PGF2a during early, mid- and late diestrus, and as CL age
increased, PGF2a concentrations decreased. Transportation of the luteolytic uterine
PGF2a in the mare is not like that of other species; the PGF2a is not exerted through the
local vascular pathway from the uterus but through systemic circulation (Ginther, 1974).
Cultured cells from late CL of mares had a decreased synthesis of PGF2a, which suggests
locally produced PGF2a is not the primary cause of luteolysis in this species (Watson and
Sertich, 1990). In the marc, PGF2a concentrations increase in uterine venous blood at the
time of luteal regression well before the decline in serum progesterone values (Douglas
and Ginther, 1976). There is suggestion that estradiol stimulates endometrial PGF2a
production linking it to the luteolytic process in mares (King and Evans, 1988).
Hormonal changes in the mares' estrous cycle will be reviewed in this next section.
-
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Endocrine Changes durin2 the Estrous Cycle
Estradiol and progesterone are reciprocally related, estradiol is active during
estrus. the follicular phase and progesterone is dominant during diestrus, the luteal phase.
LH and FSH are also reciprocally related, however during the few days encompassing
ovulation, both levels are significantly elevated (Mi \ler et aI., 1980). Estradiol and LH
have a similar increasing and decreasing pattern of secretion, although, estradiol peaks a
few days before LH. Progesterone increases significantly one day prior to a decrease in
LH at the beginning of diestrus and at the end of diestrus; progesterone decreases 2 days
before an increase in LH (Nett et aI., 1976). The decline in FSH prior to ovulation
corresponds to the rise in estradiol levels. FSH increases at the same time estradiol
decreases before progesterone increases at the end of estrus. At the end of diestrus,
progesterone decreases more rapidly than FSH. Inhibin is thought to reduce FSH
secretion. A significant decrease in inhibin concentrations is associated with an increase
in FSH and vice versa (Bergfelt et aI., 1991). A rise in LH, with a decline in FSH, is
associated with the final growth and maturation of the dominant ovulatory follicle
(Freedman et aI., 1979). The subsequent section will review the changes in
gonadotropins during the estrous cycle of the mare.
Gonadotropins
FSH and LH are gonadotropins secreted by the hypophysis that playa major role
in follicular growth and development. Ovarian steroidogenesis in granulosa and theca
cells is stimulated by gonadotropins through the activation of cAMP. As a result, there is
an increase of steroids, especially estradiol-17P, in plasma and follicular fluid of antral
follicles. Estradiol secretion from follicles is dependent upon FSH and LH action on
-
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granulosa and thecal cells, respectively. There have been extensive reviews on the
actions of gonadotropins in granulosa and thecal cells (Hsueh et aI., 1984; Hillier et aI.,
1995).
In mares, the concentration of LH is minimal during the anovulatory season
(Garcia and Ginther, 1976); however, during the ovulatory season the concentrations are
high only during estrus and are low during diestrus (Whitmore et aI., 1973). The mare
exhibits a longer LH surge, longer period of follicular growth and a longer estrus than
most other species (Evans and Irvine, 1975). LH may have a luteotrophic role as
indicated by the peak serum levels of LH occurring 1 to 2 days after ovulation (Evans and
Irvine, 1975). By the onset of estrus LH levels are increasing, reaching their maximum I
to 2 days after ovulation (Evans and Irvine, 1975) and then decreases over the next 4 to 6
days to the low diestrus values. Fay and Douglas (1987) found that plasma LH
concentrations were elevated when progesterone concentrations dropped below 1 ng/ml,
and that LH concentrations continued to increase until the day of or the day after
ovulation. The follicular fluid concentrations of LH are found to be higher in
presumptive ovulatory follicles on the 4th day of estrus (Fay and Douglas, 1987). An
increase in thecal LH receptors in presumptive ovulatory follicles is thought to be
important in the development of an ovulatory follicle since the increase in LH receptor in
the theca allows for increased responsiveness to basal LH concentrations permitting an
increase in androgen biosynthesis that could then be aromatized into estrogen (Fay and
Douglas, 1987). LH receptor mRNA levels also increase in granulosa cells as the largest
follicle reaches the expected time of deviation in cattle (Bodensteiner et aI., 1996, Evans
and Fortune, 1997) and the mare (Goudet et aI., 1999). As the dominant follicle grows,
...
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numbers of LH receptors in granulose cells increase (Stewart et aI., 1996). The increase
in LH receptors in granulosa cells may account for an enhanced oocyte competence and
responsiveness to the impending LH surge.
Evans and Irvine (1975) found that FSH concentrations were raised five-fold by
surges occurring at 10 to 11 day intervals during the estrous cycle of the mare. A late
estrus surge ofFSH initiated the development of up to 20 follicles, while the mid-diestrus
FSH surge may be needed for the development of follicles destined to ovulate 10-13 days
later (Evans and Irvine, 1975). In agreement with this observation, concentrations of
FSH increase after the future dominant follicle reaches 6 mm, peak 3 days later, and then
decline (Gastal et aI., 1997). Plasma FSH levels were elevated in mares between late
estrus and early diestrus, reaching a maximum of 10 ng/ml between Days 5 and 10 after
ovulation (Fay and Douglas, 1987). Before the day of the FSH peak, FSH and LH are
closely associated, but once the peak occurs, become disassociated until ovulation (Gastal
et aI., 1997). In cattle, before ovulation there is a concomitant FSH and LH surge
(Hansel and Convey, 1983), however, this is not found to occur in mares (Ginther, 1992).
Gastal et al. (1997) found that follicular deviation in the mare occurred during high LH
and low FSH concentrations. LH is not involved in the initiation of deviation, but may
playa role in the subsequent growth (Gastal et aI., 2000) and ovulation (Ginther, 1990a)
of the dominant follicle. Steroids involved in the estrous cycle of the mare will be




In the mare the steroidogenic role of the ovaries change drastically during
different stages of the estrous cycle. In general, the follicles are associated with the
production of estrogens, while the CL is associated with production of progestins.
As mentioned earlier, Short (1962), found that progesterone was the major steroid
in the CL of the mare. Progesterone from the CL is responsible for maintenance of early
pregnancy up to around 150 days in mares. In 1957, Short was the first to report
progesterone production from the equine placenta. From 150 days until term the main
source of progesterone (progesterone metabolites: Sa-pregnane metabolite, 200.-
dihydroprogesterone, 17a-hydroxyprogesterone) is the placenta (Holtan et a1., 1975;
Barnes et a1., 1975). In cattle and sheep (Donaldson et al., 1970; Katongole et al., 1973;
McNatty et al., 1973), systemic progesterone concentrations do not increase until day 3
after ovulation, but begin to increase immediately after ovulation in the mare (Stabenfeldt
et al., 1972; Plotka et al., 1975) and swine (Hansel et al., 1973). Progesterone
concentrations of mare serum during estrus has been well studied (Hughes et a1., 1972;
Sharp and Black, 1973; Holtan ct aI., 1<)73). Twenty- four hours before ovulation
through 8 h after ovulation progesterone concentrations ranged between 60 and 100
pg/ml (Plotka et a1., 1975). The concentrations increased 10 h after ovulation to 140
pg/ml and reached 346 pg/ml by 26 h after ovulation (Plotka et al., 1975). Evans and
Irvine (1975) found that progesterone levels during estrus were usually less than 0.5
ng/ml and increased after the end of estrus reaching a peak level between 5 and 14 ng/ml
7 to 10 days later. Between day 15 and 16 of the estrous cycle, period when the CL
regresses, progesterone concentrations in plasma decrease to below 1 ng/ml (Fay and
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Douglas, 1987). Follicular fluid progesterone concentrations did not differ among mares
in the late luteal phase, in early estrus, or in late estrus (Short, 1961; Fay and Douglas,
1987; Sirois et aI., 1990; Spicer et al., 1991). In atretic follicles, the level of progesterone
is lower than those in viable follicles (Kenney et aI., 1979). Watson and Hinrich (1988)
found that FF progesterone levels were significantly higher in mares with a 35 mm
follicle given hCG than mares not given heG.
Estrogen causes the mare to show behavioral signs of receptivity to a stallion. In
FF of the mare, estradiol-17~ is the major estrogen found (Short, 1962). Close to the
beginning of estrus, circulating concentrations of estrone and estradiol-17~ increase,
reaching a peak approximately 1 day before ovulation (Meinecke et aI., 1987). Estradiol
levels then begin to decrease and reach a basal diestrus level near the end of estrus (Fay
and Douglas, 1987). Maximal concentrations of plasma estradiol-17~ range from 11.5 to
141 pg/ml during estrus (Ginther, 1979; Nelson et aI., 1985). The high levels of estrogen
will cause a mare's uterus to become flaccid while in heat, which is different from other
farm species. Short (1962) suggested that the theca interna cells that line the graafian
follicle of the mare convert progesterone to estradiol-17~ and was later confirmed by Hay
et aI., (1975). Estradiol concentrations in FF increase from early to late estrus (Spicer et
al., 1991), and content of total estrogen is lower in atretic follicles than in viable follicles
(Kenney et aI., 1979). There is a 3-fold increase in estrogen and androgen in follicles
with a 3 cm diameter; this appears to be the turning point in the maturation of the equine
follicle (Kenney et al., ] 979). Fay and Douglas (1987) showed that the presumptive
ovulatory follicle has estradiol concentrations between 30- and 50- fold higher than that
in non-ovulatory follicles. More recent studies show that systemic estradiol levels
-
19
increased the day before the detection of follicle deviation (Gastal et aI., 1999b). Gastal
et aI., (1999a) found that as the larger follicle reached> 20 mm, it was responsible for the
increase in systemic estradiol concentrations. King and Evans (1988) suggested that
estradiol stimulation of endometrial PGF2a production may be the link to the luteolytic
process in the mare and that estradiol production is the result of luteal phase follicular
growth.
As ovulation approaches, in addition to increases in estradiol and progesterone in
FF, the follicular content of androstenedione (Meinecke et aI., 1987; Fay and Douglas,
1987) and testosterone (Watson and Hinrich, 1988; Spicer et aI., 1991) increases.
Follicular fluid of the mare contains mainly androstenedione with lesser amounts of
testosterone, epitestosterone, and 19-norandrostenedione (Short, 1961; Spicer et aI.,
1991). Regardless of follicle size or status there is a relationship between LH stimulation
of androgen biosynthesis in vivo and in vitro (Fortune and Annstrong, 1977; Fay and
Douglas, 1987). There is evidence in the mare and in other species, that androgens are
produced by the theca interna cells under the control of LH (Ginther, 1979; McNatty et
aI., 1984; Tsang et aI., 1985; Stewart et aI., 1995). Plasma androstenedione
concentrations remain constant during late diestrus and early estrus then increase
significantly by the 4th day of estrus (Fay and Douglas, 1987). Levels of testosterone in
plasma are elevated during mid-late diestrus, fall to basal concentrations at the beginning
of estrus, and rise again during late diestrus (Fay and Douglas, 1987). From these
findings, one could speculate that androstenedione plays an important regulatory role in
the growth and development of large, ovulatory follicles, since androgens cause an
increase in FSH production (Thompson et aI., 1991). The levels of 17P-
-
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hydroxyandrogens (testosterone, dihydrotestosterone, 3cx.- and 3~-androstandiols and
androstenediols) are lower in atretic than viable follicles (Kenney et aI., 1979).
ROLE OF IGF AND IGFBP fN FOLLICULAR DEVELOPMENT
IGFs in Follicular Steroidogenesis and mitogenesis
Insulin-like growth factors (IGF-l and -II) are single polypeptides that consist of
an intact C-peptide and three intramolecular disulfide bonds that are structurally similar
to proinsuiin. Amino acid sequences ofIGF-I and -II have high homology across
species; bovine IGF-I is 99%, 100%, 100% and 96% homologous to ovine, porcine,
human and rat, respectively (for review see, Spicer and Echtemkamp, 1995). Also,
bovine IGF-II is 99%, 97%, 96% and 96 % homologous to the ovine, porcine, human and
rat, respectively (for review see, Spicer and Echternkamp, 1995).
The presence of IGFs in the ovary was first reported by Hammond et al., (1982;
1985). Subsequently, IGF-I and/or -II have been found in the follicular fluid of cattle
(Spicer et aI., 1988), sheep (Spicer et al., 1995), horses (Spicer et al., 1991) and humans
(Jesionowska et aI., 1990). IGF-I and IGF-II mRNA has been found in ovarian tissue of
rats, women, cattle, pigs, and sheep including granulosa, thecal, stromal, and luteal cells
(Murphy et aI., 1987; Einspanier et aI., 1990; Barecca et aI., 1993; Samaras et at, 1994;
Spicer et at, 1995). These latter observations suggest that IGF-I and -II are locally
produced in the ovary. Tn follicular fluid of pigs (Hammond et at, 1988a) and cattle
(Spicer et at, 1988), concentrations ofIGF-I increase as follicle size increases. In mares,
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IGF-I concentrations in follicular fluid or serum did not change from early to late estrus
(Spicer et aI., 1991). Follicle diameter was significantly positively correlated (r =0.2 to
0.7) with FF IGF-l concentrations in mares (Spicer et aI., 1991), beef cows (Spicer et aI.,
1988), and prepubertal gilts (Spicer et a1., 1992; Echtemkamp et aI., 1994b; Hammond et
aI., 1988a). In comparison, FF IGF-II concentrations were approximately 1.5-fold higher
in small (atretic) than in large normal or atretic follicles of ewes (Monget et a1., 1993) and
in cattle (Spicer and Echtemkamp, 1995; Stewart et aI., 1996). However, IGF-II levels in
FF did not differ between small and large healthy follicles of ewes (Spicer et a1., 1995) or
gilts (Spicer et a1., 1992). Collectively, these results indicate that intraovarian production
of IGF-I and IGF-II are controlled differently and may account for their changes in FF.
Receptors for IGF and its mRNA have been found in many ovarian cells
including granulosa cells (Baranao and Hammond, 1984; Spicer et al., 1994a), thecal
cells (Hernandez et a1., 1988a; EI-Roeiy ct al., 1993; Stewart et aI., 1995), luteal cells
(Ladenheim et aI., 1984; Samoto et al., 1993), and ovarian stromal cells (Jarrett et a1.,
1985; Hernandez et aI., 1992). In cultured rat granulosa cells, addition of FSH and LH
increase numbers ofIGF-I receptors nearly three-fold (Adashi et a1., 1986, 1988), and
supplementation ofIGF-I increases LH receptor mRNA levels in granulosa and theca
cells (Adashi et aI., 1985; Cara et aI., 1990; Magoffin and Weitsman, 1994; Hirakawa et
aI., 1999) and FSH receptor mRNA levels in granulosa cells (Zhou et a1., 1997;
Minegishi et aI., 2000). Spicer et aI., (l994b) found that FSH increased numbers ofIGF-I
receptors in bovine granulosa cells of small follicles (but not large) and that granulosa
cells from large follicles have greater numbers of IGF-l receptors than small follicles. In
cultured bovine thecal cells, LH had no effect on the number ofIGF-I receptors whereas
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IGF-I increased the number of LH receptors. This heterologous upregulation between
IGF-I and gonadotropins may explain their synergistic effects on steroidogenesis (Stewart
et aI., 1995). IGF-I has been shown to have stimulatory effects on steroidogenesis and
mitogenesis in cultured granulosa and thecal cells from several species including rats
(Adashi et a1., 1985; Hernandez et al., 1988b; Cara and Rosenfield, 1988), pigs
(Hammond et aI., 1988a) and cattle (Spicer et a1., 1993; Stewart et aI., 1995). Granulosa
and theca cell proliferation and differentiation are stimulated by IGF-I and IGF-ll
(Hammond et a1., 1991; Adashi, 1994; Monniaux et aI., 1997). In the absence of
gonadotropins, IGF-I stimulates mitogenesis of granulosa and thecal cells, while with
gonadotropins, IGF-I synergistically stimulates steroidogenesis of granulosa and thecal
cells (0 iudice, 1992; Spicer and Echtemkamp, 1995).
IGF-I and IGF-II are bound to high affinity binding proteins (IGFBPs) in
biological fluids; these binding proteins are regulators ofIGF bioavailability for the target
cells (Zapf, 1995; Jones and Clemmons, 1995). Currently there are at least six IGFBPs
that have been cloned and sequenced: IGFBP-l, -2, -3, -4, -5 and -6 (for review see,
Rechler, 1993; Jones and Clemmons, 1995; Spicer and Echternkamp, 1995). The
following sections will first describe how these lGFBPs change during ovarian follicular
development and then describe the mechanisms by which these changes in IGFBP may
occur.
Changes in Follicular Fluid IGFBPs during Follicular Development
IGFBP-l was first detected in human FF in 1984 (Seppala et a1., 19R4). In
humans, IGFBP-l is produced by theca and stromal explants cultures, as well as
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granulosa cell cultures under basal conditions (Mason et aI., 1993). IGFBP-1 mRNA was
found in granulosa cells of dominant follicles of women (EI-Roeiy et aI., 1994). Whereas
it is not detectable in the rat (Nakatani et aI., 1991) or porcine (Hammond et al., 1991)
ovary. Purified human IGFBP-I inhibits FSH-induced estradiol and progesterone
production and IGF-I induced progesterone production in human granulosa cells (Mason
et al., 1992; Hillensjo et aI., 1992; Iwashita et a1., 1994). Schams et aI., (1999) has found
evidence for the local expression of IGFBP-I in the theca interna cell and granulosa cell
compartment during the final growth of bovine follicles. In the mare, IGFBP-l is thought
to be found at the 28-32 kDa band region in FF (Gerard and Monget, 1998), but the
presence of IGFBP-l in FF of the mare and cow awaits verification.
The presence ofIGFBP-2 in FF was first reported in pigs in 1991 (Mondschein et
a1., 1991), humans in 1992 (Cataldo and Giudice, 1992), and in cattle in 1994
(Echternkamp et aI., 1994a; Stanko et aI., 1994). In ovarian follicular fluid of pigs, cattle,
horses, and sheep (Spicer and Echternkamp, 1995; Echternkamp et aI., 1994ab; Stewart et
aI., 1996; Spicer et a1., 1995), IGFBP-2 is the second most prevalent IGFBP. Atretic
follicles contain more IGFBP-2 than do healthy follicles in sheep (Monget et aI., 1993),
cattle (Echternkamp et aI., 1994a), and women (Cataldo and Giudice, 1992; San Roman
and Magoffin, 1993). IGFBP-2 levels are greater in small than in medium or large
follicles in sheep (Spicer et aI., 1995), pigs (Mondschein et aI., 1991; Echternkamp et aI.,
1994b) and cattle (Echternkamp et aI., 1994a). In ovine preovulatory follicles, in situ
hybridization experiments demonstrated that JGFBP-2 is expressed in granulosa cells
(Besnard et aI., 1996a). Dominant follicles of women express IGFBP-2 mRNA (EI-
Roeiy et aI., 1994) and there are high amounts ofIGFBP-2 mRNA found in the theca
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cells of dominant follicles in rats (Nakatani et aI, 1991). In follicular fluid of dominant
follicles of cattle, the amount of IGFBP-2 decreases compared with subordinate follicles
(Stewart et aI., 1996; de la Sota et aI., 1996; Funston et aI., 1996). In the mare, the
binding activity of intrafollicular IGFBP-2 decreases during growth of the dominant
follicle and is elevated in subordinate follicles (Gerard and Mongel, 1998). These
changes may be due to changes in local synthesis since ovine follicles have decreased
IGFBP-2 mRNA in large healthy versus atretic follicles (Besnard et aI., 1996a) and
porcine dominant follicles contain IGFBP-2 mRNA (Yuan et al., 1996). In cattle,
IGFBP-2 rnRNA from granulosa cells was nearly undetectable in dominant follicles,
whereas in subordinate follicles there was an abundance of IGFBP-2 mRNA (Yuan et al.,
1998). Follicular fluid levels of IGFBP-2 are negatively correlated to follicular fluid
levels of estradiol and androstenedione in cattle (Echternkamp et aI., 1994a; Stewart et
aI., 1996) and sheep (Spicer et aI., 1995), and suggest IGFBP-2 may inhibit
steroidogenesis. Indeed, Spicer et aI., (1997) found that IGF-I induced androstenedione
production was weakly inhibited by IGFBP-2 in bovine thecal cells, however, LH-
induced androstenedione production in the absence ofIGF-I was not effected by IGFBP-
2.
The 42-44-kDa IGFBP, IGFBP-3, is the major IGF-binding protein in FF and its
levels do not vary with physiological status of the follicle of mares (Gerard and Monget,
1998), sows (Howard and Ford, 1992), women (Cataldo and Giudice, 1992; San Roman
and Magoffin, 1993), and cows (Echtemkamp et aI., 1994a; Funston et aI., 1996). The
detection of IGFBP-3 mRNA within porcine (Zhou et al., 1996), ovine (Perks and
Wathes, 1996), and bovine (Yuan et aI., 1998) follicles using in situ hybridization have
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not been successful, although porcine granulosa cells produced IGFBP-3 in vitro (Grimes
and Hammond, 1994). EI-Roeiy et aI., (1994) found mRNA for IGFBP-3 to be present
only in the theca layer of small, androgenic follicles of women. However, in dominant
follicles, mRNA for IGFBP-3 is found in both theca and granulosa cells (EI-Roeiy et a1.,
1994). In the rat ovary, IGFBP-3 mRNA is localized to corpora lutea (Erickson et a1..
1992). For cattle it was hypothesized that the source ofFF IGFBP-3 (Echtemkamp et al.,
1994a) is transudation from blood plasma and not follicular IGFBP-3 synthesis, which
Yuan et al., (1998) confinned. Whether this is the case for mares will require further
study.
In bovine thecal cells, IGFBP-3 had no effect on LH-induced androstenedione or
progesterone production (Spicer et al., 1997). However, the stimulatory effects ofIGF-I
on progesterone and androstenedione production were reduced by IGFBP-3 (Spicer et aL
1997). Similarly, recombinant human IGFBP-3 inhibited FSH-induced estradiol and
progesterone production and IGF-I-induced amino acid uptake but had no effect on FSH-
induced progesterone production by human granulosa cells (Mason et a1., 1992; Hillensjo
ct aL., 1992; Iwashita et aI., 1994) or bovine granulosa cells (Spicer and Chamberlain,
1999). In rodents, IGFBP-3 attenuated the inhibitory effect of hCG and IGF-I on
follicular cell apoptosis (Chun et a1., 1994) and inhibited FSH from suppressing apoptosis
(Flaws et a1., 1995). Thus, IGFBP-3 inhibits IGF-I stimulated functions of granulosa and
thecal cells of several species.
The smallest (i.e., 24-kDa) and least prevalent IGFBP in FF of all species studied
to date, including the mare, is IGFBP-4 (Gerard and Monget, 1998). In follicular fluid of
dominant follicles from cattle, the amount of IGFBP-4 decreased (Stewart et al., 1996; de
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la Sota et al., 1996; Funston et al., 1996), while IGFBP-4 levels increased with atresia of
the dominant follicle and in subordinate follicles compared to E2 active dominant follicles
(de la Sota et al., 1996). Funston et a1., (1996) observed small follicles to contain
IGFBP-4, as determined by immunoprecipitation. Through in situ hybridization, theca
cells of ovine preovulatory follicles have been shown to express IGFBP-4 mRNA
(Besnard et al., 1996a). During growth of antral follicles in sheep, there is a decrease in
the 24-kDa species (Monget et al., 1993). Cataldo and Giudice (1992) reported an
increase in IGFBP-4 in the fluid of atretic follicles of women. A 26-kDa, 24-kDa, and a
16.5-kDa band for IGFBP-4 were seen in human FF following immunoblotting (Cwyfan-
Hughes et al., 1997). In FF of atretic human follicles, the 24-kDa band was the
predominate fonn ofIGFBP-4, while in dominant follicles most of the IGFBP-4 present
was fragmented (Cwyfan-Hughes et al., 1997). IGFBP-4 is produced in porcine (Grimes
et al., 1994a) and rat granulosa cells (Erickson et al., 1992), whereas in cattle, the
expression ofIGFBP-4 mRNA is confined to theca tissue (Annstrong el al., 1998).
IGFBP-4 mRNA is localized to atretic granulosa cells in the rat ovary (Erickson et aI.,
1992) and in both the theca and granulosa cell layers of small, androgenic follicles and
large dominant follicles of women (El-Roeiy et al., 1994). Therefore, changes in IGFBP-
4 levels in follicular fluid during follicular growth and atresia is likely due to changes in
local production of IGFBP-4. Also, there is evidence of proteolysis regulating IGFBP-4,
which will be reviewed in detail in a later section.
In bovine follicular fluid, a 29- to 32-kDa IGFBP has been tentatively identified
as IGFBP-5 by western immunoblotting (Stanko et al., 1994; Funston et al., 1996.
Preovulatory follicles of sheep express IGFBP-5 mRNA in thecal cells (Besnard et a1.,
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1996a). Similar to IGFBP-2 and -4, the amount of IGFBP-5 decreases in follicular fluid
of dominant follicles from cattle (Stewart et al., 1996~ de la Sota et a1., 1996; Funston et
al., 1996), however IGFBP-5 levels increase with atresia of the dominant follicle and in
subordinate follicles compared to Ezactive dominant follicles (Echternkamp et aI., 1994;
de la Sota et aI., 1996; Stewart et al., 1996). The greatest levels ofIGFBP-5 were found
in small follicles as detennined by using immunoprecipitation (Funston et al., 1996) and
ligand blotting (Stewart et al., 1996). During the first follicular wave of the bovine
estrous cycle, IGFBP-5 activity was greater in subordinate small « 6 mm in diameter)
and large (~ 6 mm in diameter) follicles compared with early dominant follicles (Stewart
et al., 1996), which has been confirmed by others (Carolan et al., 1996~ de la Sota et al.,
1996). In FF of some early dominant follicles of mares, the 28-32-kDa IGFBP bands
representing IGFBP-S were present and then were undetectable in the subsequent
maturation stages ofhealthy follicles (Gerard and Monget, 1998). IGFBP-5 mRNA was
expressed in the theca and granulosa cell layers of small, androgenic follicles, as well as
in large dominant follicles of humans (EI-Roeiy et al., 1994). In the rat ovary, mRNA is
expressed in atretic granulosa cells, corpora lutea, and surface epithelium (Erickson et al.,
IY92). Porcine (Grimes et al., 1994a) and rat (Erickson et al., 1992) granulosa cells
produce IGFBP-5. Therefore, as with IGFBP-2 and -4, changes in IGFBP-5 levels in FF
during follicular growth and atresia is likely due to changes in local production of
IGFBP-5. Proteolysis ofIGFBP-5 is also a likely possibility that will be discussed in a
later section.
Within the ovary, IGFBP-6 gene has been localized in the rat theca-interstitial
compartment (Rohan et aI., 1993), it appears to be produced by rat granulosa cells.
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Human IGFBP-6 mRNA is found in thecal, stromal, and granulosa cells, using RT-PCR
(Voutilainen et aI., 1996). IGFBP-6 has been identified in porcine follicular fluid
(Shimasaki et aI., 1991), but because IGFBP-6 is not found in porcine granulosa cells,
IGFBP-6 may be produced by other ovarian cells in the pig (Shimasaki et a1., 1991).
REGULATION OF IGFBPs
Regulation of Follicular Cell IGFBP Gene Transcription
Proteolysis, posttranslational modification (phosphorylation), differential
localization of the IGFBPs (on the cell surface or in the extracellular matrix) are all
physiologic processes that result in a change in the affinity of IGFBPs for their ligands
thus altering target cell actions (Clemmons, 1993; Jones and Clemmons, 1995).
Because high levels of FSH are found in dominant follicles (McNatty et aI., 1975)
and granulosa cell production of IGFBPs are inhibited by FSH (Adashi et a1., 1991), it
has been postulated that IGFBP gene expression in dominant follicles is inhibited by
large quantities of FSH (Erickson et a1., 1992). The expression of IGFBP-4 mRNA is
very profound in atretic cohort follicles (Erickson et a1., 1992), and after the preovulatory
surge of LH (Smith et aI., 1975). Erickson et a1., (1992) theorized that IGFBP-4 gene
transcription in granulosa cells of cohort graafian follicles are activated by a honnonal
response, likely LH, that result in their destruction. In bovine follicles, FSH inhibits the
expression ofIGFBP-2 mRNA in granulosa cells, while LH enhanced IGFBP-4 mRNA
expression in thecal cells (Annstrong et aI., 1998).
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In multiple ovulators like the pig, mRNA expression for IGFBP-2 and -3 is
limited to certain times and cell types throughout ovarian development and the
reproductive cycle (Samaras et aI., 1992). In immature and preovulatory follicles there
was no difference in IGFBP-3 mRNA levels, however, in luteal ovaries there was a 10-
fold increase, with no change in IGFBP-2 mRNA levels (Samaras et al., 1992).
Granulosa cells have the greatest whereas thecal and luteal cells contain the lowest
amount ofIGFBP-2 mRNA, while IGFBP-3 mRNA was not detected in granulosa cells
(Samaras et al., 1992). Whether these changes occur in single ovulating species like the
mare, is unknown, however in the cow, there is an increase in granulosa cell IGFBP-2
mRNA during atresia (Armstrong et aI., 1998). What hormones, ifany, regulate IGFBP-
2 synthesis in the mare is also unknown.
IGFBP-5 mRNA is found in granulosa cells of atretic preantral and antral foHicles
in rats (Erickson et aI., 1992). Because IGFBP-5 mRNA levels in granulosa cells ofrats
are inhibited by FSH, FSH may be inhibiting IGFBP-4 and -5 gene transcription or
increasing IGFBP-4 and -S mRNA degradation in the rat (Liu et al., 1993). Theca tissue
of healthy bovine follicles was found to express IGFBP-4 mRNA, the expression did not
change during growth of the follicle (Armstrong et al., 1998). Whether IGFBP-4 and -5
are produced by ovarian cells of mares is unknown and whether IGFBP-S is produced in
ovarian cells of cows is unknown.
Posttranslational modifications of IGFBPs
Through posttranslational changes (e.g. phosphorylation), the affinity of IGFBPs
for IGF-I and -II can be modulated (Monget et aI., 1996). Phosphorylation ofIGFBP-l, -
2, -3, and -S has been shown (Clemmons, 1993). At the end of pregnancy, in human
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amniotic fluid the affinity of IGFBP-l for IGFs was reported to be increased by
phosphorylation (Koistinen et al., 1993). Jones et aI., (1993a) found that the serine
residues 101, 119, and 169 ofIGFBP-l could be post-translationally phosphorylated.
Phosphorylated IGFBP-l is present in adults and has a higher affinity for IGF-I than does
the non-phosphorylated fonn (Jones et aI., 1991; Westwood et aI., 1997) and
phosphorylated fonus migrate on J2% SDS-PAGE much faster than do the
nonphosphorylated forms (Jones et aI., 1991). The affinity of non-phosphorylated
IGFBP-1 for IGF-I is similar to that of IGF-I receptor. Phosphorylated IGFBP-l,
however, has a greater affinity to IGF-I than does the type 1 IGF receptor, allowing the
IGF-I to bind to the binding protein rather than the receptor, inhibiting IGF activity
(Westwood, 1999). Glycosylation ofIGFBP-3, -4, -5 and -6 occurs (Jones and
Clemmons, 1995), IGFBP-4 has aN-linked glycosylation site while IGFBP-5 and -6 do
not, but are O-glycosylated (Clemmons, 1993). It is known that IGFBP-l and -2 are not
glycosylated (Clemmons, 1993). The functional significance of glycosylation is
undetermined (Jones and Clemmons, 1995). So far, results indicate neither glycosylation
nor phosphorylation appear to have much influence on IGF binding affinities of IGFBP-
3, -4, -5, and -6 (Hoeck and Mukku, 1994; Coverley and Baxter, 1995).
When IGFBPs are bound to the extracellular matrix, like IGFBP-5 (Jones et aI.,
1993b), or are proteolysed (IGFBP-3, IGFBP-4, and IGFBP-5), the affinity of IGFBPs
for IGFs are reduced (Monget et al., 1996). There is an eightfold reduction in the affinity
of IGFBP-5 for IGF-I and a 60% increase in cell growth stimulated by IGF-I when
IGFBP-5 is bound to the extracellular matrix (Clemmons, 1993). When IGFBP-3 is
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bound to cell surfaces there is an enhancement of!GF action and a 10- to 12-fold
decrease in its affinity for IGF-I and IGF-II (Clemmons, 1993).
Proteolysis of IGFBPs
Modulation of IGFBP levels in various tissues has been linked to proteolytic
activity, thus affecting IGF bioavailability. Grimes and Hammond (1994) theorized
that by cleaving the intact IGFBPs into fragments, the resulting degradation could release
bound IGF from the binding proteins, thus leading to follicular growth and maturation.
Most of the IGFBPs proteolytic fragments do not bind IGF-I (Rajaram et aI., 1997).
Extracellular IGF stabilization and fine-tuning of IGF activity could be a result of a
decline in IGFBP degradation (Grimes and Hammond, 1994).
A postulated theory about increasing IGF availability involves the interaction of
IGFBP-3 and the low molecular weight binding proteins (for review see, Rajaram et aI.,
1997). The binding of IGF-I to IGFBP-3 is known to increase the half-life of IGF-I from
approximately 20 to 30 min in the free form to 15 to 20 h in the bound form (Zapf et aI.,
1986). IGFs may either remain free or bind to a lower molecular weight IGFBP and
cross the endothelium once they are dissociated from IGFBP-3. A protease may degrade
the low molecular weight IGFBP once IGF is transported into the tissue space, thus
releasing and enabling IGF-I and -11 to bind to their respective receptors. Intact IGFBP-3
has been found in follicular compartments; thus, proteolysis can not fully explain how
IGF passes the endothelial barrier. During preovulatory maturation in pigs, intrafollicular
IGFBP-3 activity is enhanced due to the increased vascularity and permeability of the
follicle during follicular growth, as hypothesized by Grimes et aI., (1 994b). However,
32
this does not occur in cattle (Echtemkamp et a1.. 1994a). IGFBP proteolysis was
originally described in the circulation of pregnant women (Giudice et aI.. 1990a;
Hossenlopp et aI., 1990). Modified or cleaved binding proteins are present in most. if not
all extra circulatory fluids. as found by subsequent work (Lalou and Binoux. 1993; Xu S
et a1.. 1995; Matsumoto et aI.. 1996). The following paragraphs will review published
evidence for IGFBP proteolysis in ovarian follicular fluid.
Evidence ofIGFBP-2 proteolysis exists for bovine (Stanko et aI.. 1994), ovine
(Besnard et aI.. 1996b; Monget et a!.. 1996) and porcine (Besnard et aI., 1997) follicular
fluid. and human thecal- and stromal-conditioned medium (Mason et aI., 1996). In ovine,
follicular fluid proteolysis of IGFBP-2 is enhanced during terminal follicular growth of
antral follicles (Monget et aI., 1996). In bovine follicular fluid of dominant and
subordinate follicles, two non-IGF binding fragments ofIGFBP-2. approximately 22- and
14-kDa. existed along with the intact IGFBP-2 (34-kDa) as detected by immunoblotting
(Stanko et aI., 1994). In human thecal- and stromal-conditioned medium. detected by
immunoblotting. an intact band of IGFBP-2 was reported at 35-kDa as well as several
lower molecular weight bands at 33-, 32-,25-.23-.20.5-, and 16-kDa. the latter of which
are thought to be products of proteolysis (Mason et aI., 1996). However, immunoblotting
may not detect all proteolytic fragments of a particular IGFBP and may detect fragments
of other IGFBPs.
Proteolytic degradation ofIGFBP-2 by ovine follicular fluid from follicles of
different classes was inferred after detecting multiple bands of low molecular weights via
immunoblotting (Besnard et aI., 1996b). There is a slight increase in IGFBP-2
proteolytic activity during ovine follicular growth, as medium follicles have greater
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proteolytic activity than in small follicles (Besnard et al., 1996b). Atretic and healthy
ovine medium follicles had similar proteolytic activity (Besnard et al., 1996b).
In porcine growing follicles 2 to 7 mm in diameter, proteolytic activity for
IGFBP-2 was found in follicular fluid; in atretic follicles there was a marked decrease in
IGFBP-2 proteolytic activity, as detected by immunoblotting (Besnard et a1., 1997). A
16-kDa fragment was detected by immunoblotting porcine preovulatory follicular fluid
incubated with recombinant human IGFBP-2 (Besnard et aI., 1997). EDTA (a calcium
chelator) and 1,10 phenanthroline (a chelator of zinc ions) was found to inhibit IGFBP-2
proteolysis of porcine follicular fluid from preovulatory follicles (Besnard et at, 1997).
The IGFBP-2 proteolytic activity that was inhibited by EDTA was completely restored
by the addition of calcium chloride and zinc chloride (Besnard et al., 1997). The addition
of PMSF (a serine protease inhibitor), aprotinin (a serine protease inhibitor), benzamide
(a serine protease inhibitor), E64 (a cysteine protease inhibitor), phosphoramidon (an
endopeptidase inhibitor), and leupeptin (a trypsin-like serine and cysteine protease
inhibitor) in porcine follicular fluid resulted in little or no inhibition of porcine IGFBP-2
proteolysis (Besnard et al., 1997). These studies suggest that the protease(s) involved in
the degradation of IGFBP-2 in porcine follicular fluid belong to the metalloprotease
family and are calcium- and zinc-dependent (Besnard et aI., 1997). Caution should be
exerted when interpreting the data because not all IGFBP-2 proteolytic fragments may
have been detected by the antisera used during immunoblotting.
Several biological fluids contain IGFBP-3 protease activity, including follicular
fl.uid from women (Giudice et al., 1990b; Hossenlopp et al., 1990; Davies et a1., 1991),
pigs (Besnard et a1., 1997), sheep (Besnard et a1., 1996b; Monget et a1., 1996), rats
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(Davenport et al., 1990; Gargosky et al., 1990), and mouse pregnancy serum (Fielder et
al., 1990), and human seminal plasma (Cohen et aI., 1992). Proteolytic activity of
lGFBP-3 is decreased during terminal follicular growth of antral follicles of sheep
(Monget et aI., 1996). In small (2-3 mm) ovine follicles, the proteolytic activity of
lOFBP-3 increases (Monget et aI., 1996). During lGFBP-3 proteolysis, low molecular
weight fragments have been detected by Western immunoblots, but as with IGFBP-2,
these fragments do not bind IOF-l or -II, and not all fragments may be detected using
immunoblotting. Cwyfan-Hughes et aI., (1997) detected via immunoblotting, intact
IGFBP-3 (41.5- and 44-kDa) as well as a lower molecular weight doublet (30- and 32-
kDa) in cultured human thecal explants from dominant follicles. As the size of the
dominant follicle increased the proportion of lOFBP-3 appearing as a 30- and 32-kDa
doublet increased from 2 to 78% (Cwyfan-Hughes et aI., 1997). Also using
immunoblotting, ovine follicular fluid from small atretic follicles was found to degrade
lGFBP-3, and EDTA and 1,10 phenanthroline blocked the degradation ofIGFBP-3
(Besnard et aI., 1996b). The addition of calcium chloride partially reversed EDTA's
effect and was totally opposed by the addition of both calcium and zinc chloride, and the
effects of 1,10 phenanthroline were negated by the addition of zinc chloride (Besnard et
aI., 1996b). Thus, intrafollicular ovine IGFBP-3 proteolytic activity is similar to that of
lGFBP-2 in pigs, in that it involves calcium- and zinc-dependent metalJoproteases
(Besnard et aI., 1996b).
The regulation of lGFBP-3 proteolysis is believed to be hormonally controlled.
Diabetes mellitus patients that are non-insulin dependent, were administered insulin and
it was found that lGFBP-3 protease activity decreased, suggesting that insulin may have a
35
role in regulating IGFBP-3 proteolysis (Bang et aI., 1994). Conversely, western
immunoblots demonstrated that insulin (40% intact IGFBP-3) or EGF (26% intact
IGFBP-3) treatments did not have a significant effect on IGFBP-3 proteolysis, when
compared to controls (37% intact IGFBP-3) in cultured porcine granulosa cells (Grimes
and Hammond, 1994). The addition of IGF-I or -II to porcine granulosa cell cultures
diminished the proteolysis of IGFBP-3, however, FSH (29%), estradiol (20%), and GH
(23%) did not significantly affect proteolysis (Grimes and Hammond, 1994). Since
insulin was i.neffective in preventing degradation of IGFBP-3, a non-receptor-mediated
action oflGF-l was proposed to regulate IGFBP proteases (Grimes et a1., 1994b).
The existence of an ovarian IGFBP-4 protease was first reported in 1994 (Adashi
et a1., 1994; Erickson et aI., 1994). Subsequently, protease activity for IGFBP-4 has been
reported in dominant estrogenic follicles of women (Chandrasekher et a1., 1995), porcine
(Besnard et a1., 1997) and ovine follicular fluid (Besnard et aI., 1996b; Monget et al..
1994; Mazerbourg et aI., 1999), porcine (Cohick et aI., 1993) and human (Kamyar et a1.,
1994) smooth muscle cells, endometrial stromal cells (Irwin et aI., 1995) and deciduas
(Myers et a1.. 1993). The IGFBP-4 protease activity in human follicular fluid was pH and
temperature dependent (Chandresekher et aL, 1995). Protease activity is induced
between temperature ranges of25 to 37°C, with the maximum IGFBP-4 reduction
occurring at 3rC (Chandrasekher et a1., 1995). A pH range of7 to 9 produces optimal
protease activity (Chandrasekher et aI., 1995). Proteolysis ofIGFBP-4 is enhanced
during tenninal follicular growth of antral follicles of sheep (Monget et aI., 1996).
IGFBP-4 proteolytic activity in large (> 5 mm) follicles decreases during follicular atresia
(Monget et aI., 1996). The protease degrading IGFBP-4 from porcine follicular fluid
--
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exists in growing, healthy follicles ranging from 2 to 7 rom in diameter, which is similar
to porcine IGFBP-2 protease (Besnard et aI., 1997). Inhibition ofIGFBP-4 degradation
in porcine (Besnard et aI., 1997) and ovine (Besnard et aI., 1996b) follicular fluid samples
is possible with the addition of EDTA and 1,10 phenanthroline (Besnard et aI., 1997),
suggesting that the follicular IGFBP-4 protease is a calcium- and zinc-dependent
metalloprotease, which is similar to the follicular fluid protease found to degrade IGFBP-
2 and -3 in sheep and pigs. In porcine smooth muscle cells, an intact 24-kDa IGFBP that
coincides with nonglycosylated IGFBP-4, is proteolytically cleaved to a 16-kDa fragment
which is not capable of binding IGF-I/-ll (Cohick et aI., 1993). Exposure of these cells to
insulin had no effect on IGFBP-4 proteolysis, however exposure to IGF-I will increase
the amount ofIGFBP-4 fragments (Cohick et aI., 1993).
In cultured human granulosa cells, FSH and estradiol have been shown to induce
IGFBP-4 proteolysis; IGFBP-4 proteolytic activity in medium was analyzed by an
IGFBP-4 protease assay and was assessed by the amount of proteolysis of iodinated
IGFBP-4, via SDS-PAGE (Iwashita et aI., 1996). It remains unknown if estradiol and
FSH directly stimulate the production of a protease by granulosa cells or if it activates
proteolytic activity through IGF-mediated mechanisms. lwashita et aI., (1998) found that
the addition of IGF-I, but not FSH, to granulosa cell cultures activated the proteolysis of
125I_IGFBP_4, indicating that the binding of IGFs to IGFBP-4 induces the susceptibility
of IGFBP-4 to proteolysis, exactly opposite to what was reported for the IGFBP-3
protease produced by porcine granulosa cells (Grimes et aI., 1994). IGFBP-4 inhibits
IGF-I stimulated estradiol release by rat (Liu et aI., 1993) and human (Iwashita et aI.,
1996) granulosa cells in vitro. Also, the addition ofIGFBP-4 to rat granulosa cells
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cultured in the presence of either 100 or 30 ng/ml of FSH inhibited estradiol production
(Ui et aI., 1989; Liu et a!., 1993). A decrease in intrafollicular IGFBP-41evels during
follicular growth is not associated with a decrease in expression in the corresponding
mRNA, and thus the absence of IGFBP-4 protein in follicular fluid from the preovulatory
follicles may be due to proteolytic degradation (Fowlkes et aI., 1995). IGFBPs in human
follicular fluid also influence IGFBP-4 degradation. Cwyfan-Hughes et aI., (1997) found
that IGFBP-4 protease activity is significantly reduced by adding unsaturated IGFBP-l. -
2, -3, or -4, as shown by Western immunoblots. Thus, a reduction in IGF-I levels,
whether due to a decrease in its local production or due to an increase in other IGFBPs,
may increase IGFBP-4 proteolysis.
Evidence for proteolysis ofIGFBP-5 has been found in bovine (Stanko et aI.,
1994), ovine (Besnard et aI., 1996b; Monget et aI., 1996) and porcine (Besnard et aI.,
1997) follicular fluid and serum of neonatal fasted pigs (McCusker et aI., 1991), as well
as in cultured rat granulosa cells (Fielder et aI., 1993), human fibroblasts (Camancho-
Hubner et aI., 1992), and porcine smooth muscle cells (Cohick et aI., 1993). Western
immunoblotting detected a 21-kDa fragment in bovine follicular fluid that reacts to the
IGFBP-5 antiserum, along with an intact IGFBP-5 doublet (31- and 32-kDa) (Stanko et
aI., 1994). These fragments coincide with IGFBP-5 fragments found in serum of
neonatal fasted pigs (McCusker et aI., 1991), and in media conditioned by porcine
smooth muscle cells (Cohick et aI., 1993) and human fibroblasts (Camancho-Hubner et
aI., 1992). In bone cells, calcium-dependent serine proteases and matrix metalloproteases
degrade IGFBP-5 (Gabbitas et aI., 1996).
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Using Western immunoblotting techniques, an intact 29-kDa (nonreduced) and
34-kDa (reduced) intact bands for IGFBP-5 are lost and a 16-, 17- and 20-kDa hand
appears during the incubation of human osteosarcoma cell-conditioned medium, IGFBP-
5 is not protected from proteolysis by the addition of either IGF-I or -II (Conover and
Kiefer, 1993). In ovine and porcine small atretic follicles, IGFBP-5 proteolytic activity
decreases significantly and in medium and large follicles IGFBP-5 proteolytic activity
was lower in atretic versus healthy follicles (Besnard et aI., 1996b; Monget et aI., 1996;
Besnard et aI., 1997). In healthy growing follicles of ovine and porcine, there is an
increase in proteolytic activity degrading IGFBP-5 (Besnard et aI., 1996b; Besnard et aI.,
1997). In porcine, there was approximately 55% IGFBP-5 proteolytic activity in small,
nonnal follicles and increased with follicle growth reaching more than 90% in
preovulatory follicles, percentages are based on densitometric analysis of Western ligand
blots (Besnard et aI., 1997). In ovine follicular fluid, IGFBP-5 proteolysis is completely
inhibited by EDTA and 1, I0 phenanthroline and can be partially restored by the addition
of calcium chloride and/or zinc chloride (Besnard et aI., 1996b; Besnard et aI., 1997).
Collectively, these results indicate that ovine and porcine follicular fluid contains one or
more metalloproteases that degrade IGFBP-2, -3, -4, and -5 (Besnard et aI., 1996b;
Besnard ct aI., 1997).
Protease activity for IGFBP-5 may be modulated by various honnones and
growth factors. Cortisol may enhance IGFBP-5 protease activity in bone cells (Gabbitas
et aI., 1996), whereas FSH induces production of an IGFBP-5 protease in rat granulosa
cells (Fielder et a!., 1993; Liu et aI., 1993). Proteolytic activity of IGFBP-5 is blocked by
IGF-I or -II in granulosa cells (Fielder et aI., 1993) and fibroblast-conditioned medium
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(Camancho-Hubner et aI., 1992). FSH may induce an IGFBP-5 protease, or it may
decrease an IGFBP-5 protease inhibitor, which could lead to the activation of the IGFBP-
5 protease.
There have been few investigations concerning a protease for IGFBP-6. In an
investigation ofthe degradation of nonglycosylated and glycosylated IGFBP-6,
glycosylated IGFBP-6 was shown to have a greater resistance to proteolysis than
nonglycosylated IGFBP-6 (Neumann et al., 1998). Chymotrypsin was incubated with
IGFBP-6, and was found to cleave intact nongylcosylated and glycosylated IGFBP-6
with 1 ng and 10 ng chymotrypsin, respectively (Neumann et a!., 1998). Additional
research is needed to further determine ifIGFBP-6-specific proteolytic enzymes do in
fact exist within the ovary.
In summary, recent studies have revealed intrafollicular proteases to be involved
in degrading IGFBPs in follicular fluid. FSH has been shown to induce the production of
a protease in rat granulosa cells that degrades IGFBP-4 and -5 (Liu et a!., 1993). Besnard
et aI., (l996b) have shown follicular fluid of ovine preovulatory follicles to contain a
metallo-dependent protease which can degrade IGFBP-4, -5 and lesser amounts of
IGFBP-2. Gonadotropins in growing healthy follicles decrease the expression of IGFBPs
<40-kD and increase secretion of protease(s) that degrade locally and peripheric IGFBPs
<40-kD (Monget et aI., 1996). In contrast, atretic foUicles exhibit an increase in the
expression of IGFBPs <40-kD. IGFBP -2, -3, -4 and -5 are proteolytically cleaved by
porcine and ovine, IGFBP-2 and -5 in bovine, IGFBP-3 and -4 in women, and IGFBP-3
and -5 in rat follicular fluid. The protease(s) involved in the degradation of IGFBP-2, -3,
-4 and -5 is thought to belong to the metalloprotease family ami are calcium- and zinc-
-
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dependent (Besnard et aI., 1997). Honnones are believed to control the regulation of
IGFBP-3; insulin may playa role in IGFBP-3 proteolysis (Bang et aI., 1994). In porcine
granulosa cells, the addition ofIGF-I or-II diminishes the proteolysis of rhIGFBP-3, yet
FSH, estradiol and GH had no significant effect (Grimes and Hammond et aI., 1994).
Insulin had no effect on IGFBP-4 proteolysis, however IGF-I increased the amount of
IGFBP-4 fragments (Cohick et aI., 1993). FSH and estradiol have been shown to induce
IGFBP-4 proteolysis in women (Iwashita et aI., 1996). The reduction of IGF-I levels
may increase IGFBP-4 proteolysis in women (Cwyfan-Hughes et aI., 1997). FSH
induces the production of a protease for IGFBP-5 in rat granulosa cells (Fielder et aI.,
1')93; Liu et aI., 1993). Thus, it appears that proteolysis of IGFBPs and the honnonal
regulation of proteolysis are species specific.
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CHAPTER III
CHANGES IN FOLLICULAR FLUID STEROIDS, INSULIN-LIKE GROWTH
FACTORS (IGFs) and IGF BINDING PROTEINS (lGFBP) AND IGFBP
PROTEOLYTIC ACTIVITY DURING EQUINE FOLLICULAR DEVELOPMENT.
ABSTRACT: Final growth of ovulatory follicles in the mare is characterized by
increased steroidogenesis and changes in lGFBP. The objective of the present study was
to evaluate changes in equine follicular fluid (FF) steroid, IGF and IGFBP content as
well as IGFBP proteolytic activity during foJlicular development. Mares (n=14) were
classified as either in the follicular phase (n = 8) or luteal phase (n = 6). Follicles (n=92)
were categorized as small « 16 rom), medium (16-25 mm), or large (> 25 rom), and
follicular fluid was collected. Follicular fluid estradiol and androstenedione levels were
greater (P< 0.05) and IGFBP-3 levels tended to be greater (P < 0.10) in large than in
small or medium follicles, whereas lGFBP-2, -4 and -5 levels were less (P< 0.05) in large
than in small or medium follicles. Estradiol and androstenedione concentrations were
negatively correlated (P< 0.01) with IGFBP-2, -4, and -5 but not IGFBP-3 levels. To
evaluate proteolysis of IGFBPs, FF was incubated with human 125 I-labeled IGFBP-2, -3,
and -5 and protein separated by 12% SDS-PAGE. Follicular fluid did not cause
proteolysis of 125I-lableled IGFBP-2 or -3. However, 125I-labeled IGFBP-5 was cleaved
(P< 0.05) by FF from large follicles collected during the follicular phase, but not luteal
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phase indicating that a protease to IGFBP-5 exists in estrogen dominant follicles. This
IGFBP-5 protease was inhibited by kallikrein/serine and metalloprotease inhibitors.
Little or no IGFBP-5 proteolytic activity was detected in FF from small or medium
follicles from follicular and luteal phase mares. We conclude that the tendency of
estrogen dominant follicles of mares to have greater levels of IGFBP-3 and lesser levels
ofIGFBP-2 do not appear to be due to differences in proteolysis, whereas changes in
IGFBP-5 levels are likely due to changes in activity of a serine protease or
metalloprotease. Changes in IGFBP may alter levels of bioavailable IGFs that stimulate
steroidogenesis and mitogenesis in developing mare follicles.
Introduction
The mare is a seasonally polyestrous, long day breeder. During the breeding season, a
mare's ovary will have multiple follicles of various sizes. One of these follicles will be
selected to deviate and become a dominant, steroidogenically active follicle, while
regression of the others occurs (Gastal et aI., 1997). This dominant follicle will continue
its growth, reaching ovulatory status with a diameter between 35 and 55 mm (Ginther and
Pierson, 1989; Spicer et aI., 1991). As follicular growth occurs, there is an increase in
follicular fluid (FF) estradiol-17~ (E2) and androstenedione (A.) levels (Kenney et a1.,
1979; Fay and Douglas, 1987; Spicer et aI., 1991).
Insulin-like growth factor-I (lGF-l) increases steroidogenesis and mitogenesis of
ovarian cells (for review, see Spicer and Echtemkamp, 1995). In cattle, sheep, and
swine, follicular growth and regression are associated with changes in insulin-like growth
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factor binding protein (lGFBP) content more than with changes in IGF-I or -II (Spicer
and Echternkamp, 1995; Stewart et aI., 1996). IGFBPs are 22-45 kDa high affinity
carrier proteins (Chan and Spencer, 1997) that bind IGF-I, prolong its half-life and block
its biological action (for review see Clemmons, 1993; Hwa et a1., 1999). Within the
ovary, IGFBPs have the ability to inhibit the synergistic effects of IGF-I and FSH (Ui et
aI., 1989; Spicer et al., 1999) and may playa role in follicular atresia (Giudice, 1992).
Follicular fluid levels of IGFBP-2, -4, and -5 decrease during follicular growth and
increase during atresia in cattle, sheep, swine and humans (for review, see Spicer and
Echternkamp, 1995; Monget et aI., 1996), while levels ofIGFBP-3 remain constant
during follicular growth in cattle (Echtemkarnp et a1., 1994a; Stewart et aI., 1996) and
humans (Cataldo and Giudice, 1992), but tend to increase slightly in sheep (Monget et
aI., 1993) and swine (Grimes et aI., 1994). A recent study in horses indicates that growth
of the dominant follicle is associated with a decrease in IGFBP-2 and IGFBP-5 whereas
IGFPB-3 and -4 are unchanged (Gerard and Monget, 1998).
IGFBPs can be regulated through changes in gene transcription or proteolysis. One
mechanism to enhance IGF-I's bioavailability to cells is through proteolysis of IGFBPs,
particularly lower molecular weight IGFBPs (Besnard et aI., 1996; Raj arm et aI., 1997).
During follicular growth in sheep, proteolytic activity for IGFBP-3 is decreased, whereas
proteolytic activity for IGFBP-4 is greatly increased and IGFBP-2 and -5 is increased to a
lesser extent (Besnard et aI., 1996). In swine, proteolytic activity for IGFBP-2, -4, and -5
increases during follicular development and there is very little or no proteolytic activity
for IGFBP-3 (Besnard et aI., 1997). Currently, little infonnation is available concerning
the proteolytic activity during folliculogenesis of the mare. Therefore, the objective of
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this study was to evaluate changes in equine follicular fluid (FF) steroid and IGFBP
levels as well as IGFBP proteolysis during follicular steroidogenesis and development.
Materials and Methods
Biological Material
FF was aspirated from follicles (n=92) of 14 cyclic mares was collected at an abattoir
and centrifuged (Langhout et a1., 1991) and FF was stored at -20°e. The mares were
classified as either in the follicular (n=8) or luteal phase (n=6) based on gross ovarian
morphology; ovaries with a viable (vasculature visible) corpus luteum (CL) were
classified as being in the luteal phase and ovaries with no CL, or with a corpus albicans
were classified as being in the follicular phase. External diameters of follicles were
measured to categorize them as being small (6-15 mm), medium (16-25 mrn), or large (>
25 mm).
Radioimmunoassays (RIA)
Concentration of estradiol-17P in FF was determined by RIA as previously described
(Spicer and Enright, 1991). The intra- and interassay coefficient of variance (CY) were
12.8 and 21.1 %, respectively. Concentrations of androstenedione in FF were determined
in a single assay using a commercial solid-phase RIA kit (lCN Biomedicals, Costa Mesa,
CA) as previously described by Stewart et al. (1996). The intraassay CY was 15%.
Concentrations of progesterone in FF were determined by RIA as previously described
by Spicer and Enright (1991). The intra- and interassay CV were 13.3 and 6.7%,
respectively. Concentrations of IGF-I in FF were determined by RIA as previously
described (Echtemkamp et al., 1990; Spicer et al., 1991). The intra- and interassay CY
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were 14.5 and 15.5%, respectively. Concentrations of IGF-I1 in FF were detennined by
RIA in a single assay as previously described Spicer et aI. (1995). The intraassay CV
was 3.2 %.
Ligand Blots
IGF binding proteins (IGFBP) in FF were analyzed by one-dimensional SDS-PAGE,
as previously described (Echternkamp et aI., 1994a; Simpson et aI., 1997). Briefly, 4 III
of FF was mixed with 21 III of denaturing buffer (BIORAD, Hercules, CA). The samples
were heat denatured (3 min at 100°C), subsequently centrifuged at 4657 X g for 3 min
and separated using 12% PAGE for about 18 to 20 h, at a constant current and varying
voltage. After separation, proteins in the gels were electrophoretically transferred to
nitrocellulose paper (Midwest Scientific, St. Louis, MO) for 2.5 to 3.0 h and ligand-
blotted overnight with 125I_IGF_II. Tris-buffered saline (TBS) with 0.1 % Tween was
used to wash the nitrocellulose blots. The nitrocellulose blots were dried and exposed to
X-ray film at -70°C for 12 d. X-ray film was then developed and band intensity on
autoradiographs was determined using scanning densitometry with a Molecular Analyst
(BIORAD, Hercules, CA).
IGFBP Iodination
IGFBP-2, -3, and -5 were iodinated by a modification of the chloramine-T method.
Recombinant human IGFBP-2 (31,000 molecular weight) was obtained from Austral
Biologicals (San Ramon, CA); recombinant human IGFBP-3 (47,000 molecular weight)
and recombinant human IGFBP-5 (30,000 molecular weight) were obtained from Upstate
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Biotechnology Inc. (Lake Placid, NY). Two micrograms ofIGFBP-2, -3, and -5 were
independently incubated with I mCi Na ['251] in the presence of3.2 Ilg chloramine-T for
30 s at 25°C. The reaction was stopped with addition of 61lg sodium meta-bisulfate. 1251_
IGFBP-2, -3, and -5 was purified from the reaction mixture by Sephadex G-50 gel
chromatography (Sigma Chemical Co., St. Louis, Mo, USA).
IGFBP Proteolysis
A subset of 36 of 92 follicles were selected for IGFBP proteolysis assay based on: 1)
the follicle with the greatest E2 concentration was selected from each mare, and 2) one
small and one medium follicle, if present, was randomly selected from each mare. FF (6
Ill) was incubated at 37°C for 5 h with 60,000 cpm of either recombinant human 1251_
.Iabeled IGFBP-2, -3, or -5. Proteolytic fragments of the various 125I_Iabeled IGFBPs
were separated by 12% SDS-PAGE. Prior to electrophoresis, samples were boiled for 3
min to denature proteins and then added to the wells in the gel. Gels were dried on a
vacuum and exposed to X-ray film for 48 h. The resultant breakdown products or lack of
were determined using scanning densitometry with a Molecular Analyist (BIORAO,
Hen:ules, CA.).
Protease Inhibitors to IGFBP Degradation
Inhibition ofFF protease activity to IGFBP was evaluated using 60,000 cpm of
recombinant human 1251-labeled IGFBP-5 in media with 0.0 I or 0.10 roM aprotinin (a
kallikrein and serine protease inhibitor), 0.10 or 1.0 mM of either phenyl methane-
sulfonyl fluoride (PMSF) (a serine, cysteine, and thiolprotease inhibitor) (Boehringer
Mannheim, Indianapolis, IN), I, IO-phenanthrohne (metalloprotease inhibitor) or
doxycycline (metalloprotease inhibitor), 0.001,0.01 or 0.10 mM cyclohexylacetyl-phe-
r
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arg-ser-val-gln amide (CAA) (kallikrein protease inhibitor) or 0.10, 1.0 or 5.0 roM EDTA
(chelates Ca++) (Sigma Chemical Co., St. Louis, MO), 6 ~l ofFF were added to each tube
and incubated at 37°C for 5 h. Samples were separated by 12% SDS-PAGE, subjected to
autoradiography, and resultant bands scanned as previously described.
Statistical analyses
Follicular fluid hormone and IGFBP data as well as proteolysis data were analyzed
using least squares ANaYA by the General Linear Models procedure of SAS (1988).
Main effects, consisting of follicle size (small, medium, large) and follicle phase
(follicular, luteal) and their various interactions were analyzed. Means were compared
using "t"-test if significant main effects were observed. Relationships among variables
measured were evaluated by simple correlation analysis (Pearson correlation coefficients)
(SAS, 1988). Means are presented as least squares means ± SE.
Results
A significant (P < 0.0001) main effect of follicle size, but not phase or size x phase
interaction (P > 0.10) was observed with follicle diameter. Diameter averaged 33 ± 1.0
nun, 17.8 ± 0.70 mm and 11.4 ± 0.48 mm, for large, medium and small follicles,
respectively.
Follicle size, phase of estrous cycle or their interaction did not affect (P > 0.10) FF
progesterone levels. FF progesterone averaged 33.4 ± 8.1 ng/ml, 23.8 ± 5.7 ng/ml and
30.7 ± 3.5 ng/mI, for small, medium and large follicles, respectively.
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Follicle size x phase interaction affected (P < 0.005) FF estradiol levels (Figure 1).
Main effects of follicle size and phase were also significant (P < 0.005). Large, follicular
phase follicles (1425.1 ± 114.2 nglmL) contained greater (P < 0.0001) levels of estradiol
than large follicles in the luteal phase (473.3 ± 228.4 ng/mL), small follicles in the
follicular (46.3 ± 77.6 ng/mL) or luteal phase (19.9 ± 74.8 nglmL), and medium follicles
in either the follicular (41.2 ±98.9 nglmL) or luteal phase (84.6 ± 149.5 ng/mL).
A significant (P < 0.0005) main effect of follicle size, but not phase or size x phase
interaction was observed for FF androstenedione levels. Large follicles had 6- to 8-fold
greater (P < 0.05) concentrations of androstenedione than small or medium follicles
(Figure 2A).
Follicle size affected (P < 0.01) FF IGF-I levels, whereas phase of estrous cycle and
size x phase had no effect on FF IGF-I levels. Large follicles contained 78% to 90%
more (P < 0.05) IGF-I than did small or medium follicles (Figure 2B).
Phase of estrous cycle tended to affect (P < 0.10), whereas size and size x phase had
no significant effect on FF IGF-II levels. Follicular phase follicles (67.7 ± 3.0 nglmL)
tended to have greater (P < 0.10) amounts ofIGF-Il than did luteal phase follicles (57.0 ±
5.0 ng/mL).
Follicle size and phase (P < 0.05), but not size x phase interaction affected
concentrations of protein in FF. FF of large follicles (145.7 ± 8.5 mglmL) had 17% to
47% greater (P < 0.05) concentrations of protein than small (100.6 ± 4.2 mglmL) and
medium (124.7 ± 5.9 mg/mL) follicles. There were greater (P < 0.05) concentrations of
protein in FF of luteal phase (131.5 ± 6.3 mglmL) than follicular phase (115.8 ± 3.9
mg/mL) follicles.
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Ligand blotting with C25I] IGF-II revealed at least six fonns ofIGFBP present in FF:
l25-l35-kDa IGFBP, l15-kDa, 90-96-kDa, 40- to 44-kDa (IGFBP-3), 34-kDa (IGFBP-
2), 27-29-kDa (IGFBP-5), and 20-22-kDa (IGFBP-4) (Figure 3). Follicle size (P < 0.01)
but not phase of cycle or size x phase interaction (P > 0.10) affected IGFBP-2 levels in
FF. Concentrations ofIGFBP-2 in small and medium follicles were 1.8- and 1.9-fold
greater (P < 0.05) than in large follicles (Figure 2C). There tended (P < 0.10) to be an
interaction between follicle size x phase on FF IGFBP-3 levels (Figure 4A). Large luteal
phase follicles had 60% greater (P < 0.05) IGFBP-3 concentrations than did large
follicular phase follicles, and had 48%, 57%, and 60% greater (P < 0.05) concentrations
ofIGFBP-3 than medium luteal, small follicular, and small luteal phase follicles,
respectively.
Follicle size x phase interaction affected (P < 0.05) IGFBP-4 levels in FF (Figure 4B).
Concentrations of IGFBP-4 were 3.0- and 2.6-fold greater (P < 0.05) in small follicular
phase and small luteal phase follicles than in both large follicular phase and medium
luteal phase follicles, respectively. Medium follicular phase follicles had 3.3-fold greater
(P < 0.05) concentrations ofIGFBP-4 than both medium luteal phase and large follicular
phase follicles.
Follicle size x phase interaction affected (P < 0.05) IGFBP-5 levels in FF (Figure 4C).
Main effect of follicle size was also significant (P < 0.005). Concentrations of IGFBP-5
in medium and small follicular phase follicles, and small luteal phase follicles were 5-,
4.1-, and 4-fold greater (P < 0.05) than in large follicular phase follicles, respectively.
Concentrations ofIGFBP-5 were 2.3- and 2.l-fold greater (P < 0.05) in medium
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follicular phase follicles than large luteal phase and medium luteal phase follicles.
respectively.
Follicle size tended (P < 0.10) to affect levels of the llS-kDa 1GFBP in FF. Small
(0.69 ± 0.09 ADU) and medium (0.81 ± 0.14 ADD) follicles had 3.1- and 3.6-fold greater
(P < 0.05) concentrations of the 115-kDa IGFBP, respectively. than did large (0.23 ±
0.20 ADD) follicles. The 135-kDa and 12S-kDa 1GFBP and were arithmetically
combined for analysis and labeled as 125-135-kDa IGFBP. Follicle size x phase
interaction affected (P < 0.05) 125-135-kDa 1GFBP levels in FF. Main effects of follicle
size were also significant (P < 0.05). Medium follicular phase follicles (2.6 ± 0.26 ADU)
had 1.5- and 1.6-fold greater (P < 0.05) concentrations of 12S-135-kDa IGFBP than did
large follicular phase (I .7 ± 0.32 ADU) and small follicular phase follicles (1.6 ± 0.23
ADU), respectively. Medium follicular and luteal phase follicles (2.1 ± 0.39 ADU) as
well as small luteal phase follicles (2.2 ± 0.22 ADU) had 3- to 4-fold greater (P < 0.05)
concentrations of 125-135-kDa IGFBP than did large luteal phase follicles (0.6 ± 0.61
ADU). Large follicular phase (3.9 ± 1.3 ADU) versus large luteal phase (0.58 ± 2.5
ADD) follicles did not differ (P > 0.10).
The 96-kDa and 90-kDa IGFBP were combined for analysis and labeled as 90-96-kDa
IGFBP. Follicle size x phase interaction tended to affect (P < 0.10) the 90-96-kDa
IGFBP levels in FF. Medium follicular phase follicles (11.9 ± 2.4 ADU) had 3.2- and
2.6-fold greater (P < 0.05) concentration of90-96-kDa IGFBP than large luteal phase
follicles (1.3 ± 5.5 ADD) and small follicular phase follicles (2.9 ± 2.1 ADD),
respectively. Medium luteal phase follicles (10.2 ± 3.6 ADU) had 2.6-fold greater (P <
0.05) concentrations of the 90-96-kDa IGFBP than did small follicular phase follicles
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(2.9 ± 2.1 ADU). Small luteal phase follicles (7.8 ± 2.0 ADU) had 2. I-fold greater (P <
0.05) concentrations of the 90-96-kDa IGFBP than did small follicular phase follicles
(2.9 ± 2.1 ADU). Large follicular phase (7.1 ± 2.9 ADU) versus large luteal phase (1.3 ±
5.5 ADU) follicles did not differ (P > 0.10).
FF caused little or no proteolysis (P > 0.10) of 125I-Iabeled IGFBP-2 or -3 (Figure 5).
Amount of 125r_Iabeled IGFBP-2 degradation (large, 24.7 ± 1.4 %; medium, 24.9 ± 1.5 %;
and small, 21.8 ± 0.98 %) after 5 h incubation was not affected (P < 0.10) by follicle size,
phase ofcycle or follicle size x phase interaction. Similarly, 125I-Iabeled IGFBP-3
degradation (large 50.2 ± 3.2 %; medium, 48.5 ± 3.4 %; and small, 45.9 ±2.3 %)was not
affected (P < 0.10) by follicle size, phase of cycle or follicle size x phase interaction.
However, 125I-labeled IGFBP-5 was cleaved more by FF from large follicles collected
during the follicular phase than the luteal phase (Figure 6). Intact IGFBP-5 migrated at
30-kDa, and breakdown products at approximately 19-kDa, 16-kDa, and 14.5-kDa
(Figure 6). A significant (P < 0.05) interaction between follicle size and phase of estrous
cycle was observed for the 30-kDa intact band with lesser amounts (P < 0.005) of the 30-
kDa band found after incubation with FF from large follicular phase follicles (68.2 ± 4.7
ADU) than from large luteal phase follicles (92.9 ± 7.6 ADU), medium follicular (86.8 ±
5.9 ADU) or luteal (90.3 ± 7.6 ADU), or small follicular (84.8 ± 3.9 ADU) or luteal (85.1
± 4.9 ADU) phase follicles.
A significant (P < 0.05) interaction was also observed between follicle size and phase
on the 19-kDa band, the most prevalent breakdown product of 1251_IGFBP_5. Large
follicular phase follicles had 2.5- to 4.3-fold greater (P < 0.05) amounts of the breakdown
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band than did all other follicle classes (Figure 7A). Follicle size and phase of estrous
cycle affected (P < 0.05) the 19-kDa breakdown product as well.
There tended (P < 0.10) to be an interaction between follicle size and phase on the 16-
kDa breakdown product of I 25I-IGFBP-5 (Figure 7B). Large follicular phase follicles
had 2.0- to 3.3-fold greater (P < 0.05) amounts of the 16-kDa band than did all other
follicle classes. Follicle size and phase of estrous cycle affected (P < 0.05) the 16-kDa
breakdown product. Large follicles (6.1 ± 1.0 ADO) had greater amounts (P < 0.05) of
16-kDa band than did small (2.9 ± 0.8 ADU), but not medium follicles (3.8 ± 1.1 ADU).
There tended (P < 0.10) to be an interaction between follicle size and phase on the
14.5-kDa breakdown product of 125I_IGFBP_5 (Figure 7C). Large follicular phase
follicles had 2.2- to 3.0- fold greater (P < 0.05) amounts of 14.5-kDa breakdown product
than did all other follicle classes. Follicle size and phase of the estrous cycle also tended
to affect (P < 0.10) the 14.5 kDa breakdown product.
Serine protease inhibitors CAA and aprotinin inhihited (P < 0.0 I) IGFBP-5 protease
activity (% of control) (Figure 8A). CAA at 0.0 I mM and 0.10 mM caused greater (P <
0.01) inhibition ofIGFBP-5 protease activity than at 0.001 roM (Figure 8A). PMSF at
1.0 roM had little or no effect on IGFBP-5 protease activity (Figure 8A). Aprotinin
inhibited IGFBP-5 protease activity to an extent similar to that of CAA; the inhibition
caused by 0.01 roM and 0.10 mM of aprotinin did not differ (P > 0.10) (Figure 8A).
The metalloprotease inhibi tors doxycycli ne, EDTA, and 1,1 O-phenanthroline affected
(P < 0.01) IGFBP-5 protease activity (% of control) (Figure 8B). Doxycycline at 1.0 roM
caused greater (P < 0.01) inhibition of IGFBP-5 protease activity than at 0.10 roM
(Figure 8B). Only 5.0 roM EDTA inhibited (P < 0.01) IGFBP-5 protease activity (Figure
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8B). I,IO-Phenanthroline caused greater (P < 0.01) inhibition ofIGFBP-5 protease
activity at 1.0 mM than at 0.10 roM (Figure 8B).
Follicular fluid E2, ~, IGF-I and IGF-II concentrations were negatively correlated (P
< 0.05) with levels of IGFBP-2 and -5 but not with (P > 0.10) IGFBP-3 levels (Table 1).
FF IGFBP-4 was negatively correlated (P < 0.05) with only FF E2 and IGF-I. Follicular
fluid P4 concentrations were negatively correlated (P < 0.05) with IGFBP-3 and IGFBP-5
but not correlated with IGFBP-2 or -4 (Table 1). Follicle size (diameter) was negatively
correlated (P < 0.05) with IGFBP-2, IGFBP-4, IGFBP-5 and positively correlated (P <
0.05) with E2 (r = 0.73),~ (r = 0.52), and IGF-I (r = 0.49). Concentrations ofE2 in FF
were positively correlated with IGF-I (r = 0.49) (P < 0.0001) and IGF-II (r =0.35) (P <
0.01).
Amount ofIGFBP-5 proteolysis was positively correlated (P < 0.01) with FF E2 levels
and to a lesser extent (P < 0.05) FF~ levels (Table 2). 125I_IGFBP_5 fragments were
negatively correlated (P < 0.0 I) with IGFBP-2 and -5 but not with IGFBP-3 or -4 (Table
2). Follicular fluid IGF-I and -II concentrations were positively correlated (P < 0.05)
with 125I_IGFBP_5 fragments (Table 2).
Discussion
Results of the present study revealed that: 1) 1251-labeled IGFBP-5 was cleaved by
mare FF from large follicles collected during the follicular phase, but not the luteal phase,
whereas FF did not cause proteolysis of 125I-labeled IGFBP-2 or -3; 2) the amount of
IGFBP-5 proteolysis was positively correlated with follicular fluid E2, ~, IGF-I and
IGF-II levels; 3) follicular fluid IGFBP-2, -4, -5 and 125-135-kDa IGFBP were less in
large than in small or medium follicles, particularly during the follicular phase; 4)
------------~-
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follicular fluid IGF-I levels were greater in large than in small or medium follicles,
whereas FF IGF-II levels tended to be greater in follicular phase vs. luteal phase follicles~
and 5) metalloprotease and serine protease inhibitors significantly reduced IGFBP-S
protease activity; in a dose dependent fashion; and 6) follicular fluid E2 and At. levels
were greater in large than in small or medium follicles and follicular phase mares had
greater E2 in large follicles vs. luteal phase mares.
For the first time, proteolysis of IGFBP-5 in mare FF has been evaluated. In
particular, we found evidence for IGFBP-5 proteolysis, but none for IGFBP-2 or -3.
Similar to the present study, evidence for proteolysis of IGFBP-5 has been found in
bovine (Stanko et aI., 1994; Spicer and Chamberlain, 2000), ovine (Besnard et aI., 1996;
Monget et aI., 1996) and porcine (Besnard et aI., 1997) FF. Similar to results found in
other mammalian species (for review, see Spicer and Echtemkamp, 1995; Monget et aI.,
1996), we observed IGFBP-5 levels to be less in large than in small or medium follicles.
In particular, IGFBP-S levels in FF of subordinate large or small follicles from cattle are
severalfold greater than in dominant follicles (Stewart et aI., 1996; de la Sota et a1.,
1996; Funston et ai., 1996). Also in agreement with the present study, intrafollicular
IGFBP-5 levels were greater in large nonovulatory and subordinate/atretic follicles of
mares (Gerard and Monget, 1998). FSH has been reported to regulate IGFBP production
by rat granulosa cells (Adashi et at, 1990; 1991). Thus, changes in intraovarian levels of
IGFBP-5 may be regulated by changes in local synthesis as well as proteolysis of IGFBP-
5. Proteolysis of 125I_IGFBP_5 was positively correlated with FF E2 (r = 0.5-0.7) and At.
(r = 0.2-0.4) levels in the present study. This latter observation coupled with the
observation that FF levels of IGFBP-5 are negatively correlated with E2 and A4 levels,
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implies either or both steroids may regulate IGFBP-5 levels via induction of protease
activity. Fielder et a1., (1993) and Liu et al., (1993), found FSH to induce an IGFBP-5
protease in rat granulosa cells in vitro, and this protease was inhibited by IGF-I or IGF-II.
Similarly, IGF-I activates IGFBP-4 protease in cultured rat granulose cells (Liu et a1.,
1993). Because IGFBP-5 protease was positively correlated (r = 0.4 to 0.5) with FF
levels of IGF-I and -II, it is unlikely that IGF-I or -II inhibits this protease activity in
mare follicles. In support of this latter suggestion, IGFBP-5 proteolysis was not altered
by IGF-I or -II in osteocarconoma cells (Conover and Keifer, 1993). Whether IGF-I and
-II directly activate IGFBP-5 protease activity in mare follicles or whether the effects are
indirect via IGF-I induction of steroidogenesis (Spicer and Echternkamp, 1995) will
require further study.
Consistent with the present study, others have reported IGFBP-2 levels are greater in
small than in medium or large follicles in sheep (Spicer et al., 1995), pigs (Mondschein et
a1., 1991; Echternkamp et aI., 1994b) and cattle (Echternkamp et a1., 1994a; Stewart et
aI., 1996). Follicular fluid of dominant follicles of cattle (Stewart et aI., 1996; de la Sota
et a1., 1996; Funston et aI., 1996) and mares (Gerard and Monget, 1998) contain less
IGFBP-2 than FF of subordinate follicles. Atretic follicles contain more IGFBP-2 than
do healthy follicles in sheep (Monget et a1., 1993), cattle (Echternkamp et a1., 1994a), and
women (San Roman and Magoffin, 1993). Proteolysis of IGFBP-2 by FF has been
reported for cattle (Stanko et a1., 1994), sheep (Besnard et a1., 1996), and pigs (Besnard et
a1., 1997). We found no evidence for FF proteolysis of IGFBP-2 in mare follicles, and
thus changes in IGFBP-2 levels are likely a result of changes in local production of
IGFBP-2 within mare follicles. This later notion awaits verification. Because FF levels
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ofE2,~, IGF-I and IGF-II were negatively correlated with FF IGFBP-21evels in the
present study, further research should focus on the role these hormones play in regulating
follicular IGFBP-2 production in the mare.
Similar to the present study, IGFBP-3 was found to be the major IGF binding protein
in FF of weaned sows (Howard and Ford, 1992), humans (Cataldo and Giudice, 1992;
San Roman and Magoffin, 1993), and cattle (Echtemkamp et aI., 1994; Funston et al.,
1996; Stewart et aI., 1996). In ewes, IGFBP-3 levels increase during follicular growth in
some (Monget et aI., 1993) but not other (Spicer et al., 1995) studies. Similarly in pigs,
IGFBP-3 content increase during follicular growth in some (Grimes et al., 1994) but not
other (Echtemkamp et aI., 1994) studies. A recent study in mares indicates that FF
IGFBP-3 levels do not vary with physiological status of the follicle (Gerard and Monget,
1998). In contrast, we found FF IGFBP-3 levels tended to be greater in large luteal phase
follicles when compared to large follicular phase follicles, but were not different among
any other classes offollic1es. Reasons for the discrepancies among studies are unknown
hut based on the present results IGFBP-3 levels may be influenced by stage of cycle
when follicles are collected. In contrast to studies in women (Giudice et aI., 1990;
Hossenlopp et al., 1990; Davies et aI., 1991), pigs (Besnard et aI., 1997), sheep (Besnard
et al., 1996) and rats (Davenport et al., 1990), we found no evidence for IGFBP-3
protease activity in FF. Whether these differences are due to species differences or due
to some other factor is unclear. Because no proteolysis of IGFBP-3 was detected in the
present study, the changes in FF IGFBP-3 observed in the mare are likely due to factors
other than proteolysis such as changes in IGFBP-3 transudation from serum as suggested
for cattle (Echternkamp et al., 1994).
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In pigs (Howard and Ford, 1992), humans (Cataldo and Giudice, 1992), and cattle
(Echtemkamp et aI., 1994a; Stewart et aI., 1996), FF IGFBP-4 levels are undetectable in
estrogen-active and dominant follicles. In atretic and late atretic follicles of sheep, the
22- to 24-kDa band (lGFBP-4) was found to be intense (Monget et aI., 1993), while in
estrogen-active preovulatory ewe follicles the 22- to 24-kDa band was undetectable using
Western ligand blotting (Monget et al., 1993; Spicer et a1., 1995). Although not
evaluated in the present study, protease activity for IGFBP-4 has been reported in
dominant estrogenic follicles ofwomen (Chandraskher et aI., 1995), mare (Mazerbourg
et aI., 2000), bovine (Mazerbourg et aI., 2000; Spicer and Chamberlain, 2000), porcine
(Besnard et al., 1997; Mazerbourg et aI., 2000) and ovine (Besnard et al., 1996;
Mazerbourg et al., 1999) FF. Experiments using in situ hybridization have shown atresia
to be characterized by an increase in IGFBP-4 gene expression in rat granulosa cells
(Nakatani et al., 1991). Thus, as with IGFBP-2 and -5, intraovarian changes in IGFBP-4
levels may be regulated by changes in local synthesis as well as proteolysis of IGFBP-4.
We found large follicular phase follicles and medium luteal phase follicles to have less
IGFBP-4 concentrations than any other class of follicles. Because absolute levels of
IGFBP-4 were minor compared with all other IGFBPs in mare FF, and Gerard and
Monget (1998) showed little or no change in IGFBP-4 levels during growth of the
dominant follicle in mares, we chose not to evaluate its proteolysis by FF. Whether these
minor changes in FF IGFBP-4 levels found in the present study are due to changes in
local synthesis or proteolysis will require further study.
Similar to a 96-kDa IGFBP found in equine serum (Prosser and McLaren, 1992) and
bovine serum (Simpson et aI., 1997), we found a 90-to 96-kDa IGFBP in mare FF. As
78
previous studies have suggested, this 90-to 96-kDa IGFBP is most likely a proteolytic
fragment of the soluble fonn of the IGF-II receptor (Westlund et aI., 1991). We also
found at least two other high-molecular weight IGFBPs in mare FF, a 115-kDa and a
125-135-kDa IGFBP. The 115- and 125-135-kDa IGFBPs are likely soluble forms of the
IGF type I receptor. Interestingly, all of these high molecular weight IGFBP changed
with follicular status, indicating that changes in IGF type I and II receptors may playa
role in follicular development in the mare.
For the first time, protease inhibitors to IGFBP-5 proteolysis in mare FF has been
evaluated. We found metalloprotease inhibitors such as doxycycline, EDTA, and 1,10-
phenanthroline, as well as serine protease inhibitors CAA, PMSF, and aprotinin
inhibited, in a dose-dependent way, IGFBP-5 protease activity, suggesting that the
IGFBP-5 protease present in mare FF is a serine-metalloprotease. The IGFBP
protease(s) that degrades IGFBP-2, -4 and -5 found in swine follicles was inhibited hy
metalloprotease inhibitors but not serine protease inhibitors (Besnard et aI., 1997).
However, a serine protease has been found to inhibit the degradation of IGFBP-3 in
swine follicles (Grimes and Hammond, 1994). The IGFBP protease that degrades
IGFBP-3, -4 and -5 found in sheep FF is a metallo-protease (Besnard et aI., 1996). [n
humans, the IGFBP protease that degrades IGFBP-4 is a metallo-serine protease
(Chandrasekher et aI., 1995).
Estradiol is the dominant steroid secreted by the preovulatory follicle of the mare at
the beginning of estrus (Kenney et aI., 1979; Meinecke et aI., 1987; Spicer et aI., 1991).
As ovulation approaches, the follicular content of androstenedione (Meinecke et a1.,
1987), testosterone (Watson and Hinrichs, 1988; Spicer et aI., 1991) and estradiol (Spicer
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et aI., 1991) increases. At 3 cm in diameter, there appears to be a turning point in the
maturation of equine follicles, in that> 3 em healthy follicles have 3- to 5-fold greater
levels of estrogens and androgens than healthy < 3 cm follicles (Kenney et aI., 1979;
Belin et aI., 2000). In agreement with these and other studies in mares (Kenney et aI.,
1979; Fay and Douglas, 1987; Spicer et aI., 1991), we found large (>25 mm) follicles in
the follicular phase to have 3-fold greater concentrations of E2 than large follicles in the
luteal phase, and 17- to 72-fold greater amounts of estradiol than small or medium
follicles in either the follicular or luteal phase. In agreement with studies in cattle (Kruip
et aI., 1979; Henderson and Franchimont, 1981; Ireland and Roche, 1982), size of antral
follicles was positively correlated with FF estradiol and androstenedione concentrations.
Increased FF E::! and fu. levels with follicular size suggest that these steroids are involved
in follicular growth and development in the mare. Consistent with this suggestion, we
found that FF E2and A.4 levels were negatively correlated with levels oflGFBP-2, -4, and
-5 but not IGFBP-3 in FF. Previous studies have also reported negative correlation
between FF estradiol and low molecular weight IGFBP levels in cattle (Echternkamp et
aI., 1994a; Stewart et aI., 1996), sheep (Spicer et aI., 1995), and mares (Gerard and
Monget, 1998). Whether E2 and A.4 regulate IGFBP levels via changes in local
production or changes in proteolysis will require further study.
Follicular fluid IGF-I and -II concentrations in dominant and subordinant follicles did
not differ in cattle (Stewart et aI., 1996), yet FF concentrations of IGF-I increase (Spicer
et aI., 1988, 1992; Echternkamp et aI., 1990; Spicer and Enright, 1991) and IGF-Il
decrease (Spicer and Echternkamp, 1995; Stewart et aI., 1996) with follicle size in cattle.
Similarly, we found FF IGF-I levels to be greater in large than in small or medium
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follicles. However, FF IGF-II levels were not different among small, medium and large
follicles but tended to be greater in follicular phase vs. luteal phase follicles. Whether
these changes in FF IGF-I and -II are due to changes in local production of these IGFs
will require further study.
In conclusion, follicular fluid E2, ~, and IGF-I levels increase in large follicles
coincident with a reduction in IGFBP-2, -4 and -5 levels and an increase in proteolysis of
IGFBP-5. Thus, increases in follicular fluid E2, ~ and IGF-I levels during the estrous
cycle of the mare may modulate development of follicles and/or atresia by affecting the
synthesis or proteolysis of IGFBPs.
Implications
Follicular growth, maturation, and atresia are IGF-dependent mechanisms that are
affected by IGFBPs. Lower molecular weight IGFBPs were found to decrease in large,
estrogenic follicles with increased E2 and IGF-1 levels. We were the first to report that
proteolysis ofIGFBP-5 by FF of the mare, and that proteolysis ofIGFBP-2 and -3 is not
present in mare FF. There is a need to focus future research on identifying the specific
hormonal regulators of IGFBP-5 protease activity, as well as evaluate if IGFBP protease
inhibitors exist in mare FF.
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Figure 1. Follicular fluid concentrations of estradiol-17B collected from small (6-15
mm), medium (16-25 mm) or large (> 25 mm) follicles in either the follicular phase or
















































Figure 2. Follicular fluid concentrations of androstenedione (Panel A), IGF-I (Panel
B), and IGFBP-2 (Panel C) collected from small (6-15 rum), medium (16-25 rum) or
large (> 25 mm) follicles in either the follicular or luteal phase in mares. a,bWithin a
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Figure 3. Representative ligand blot of IGFBPs in follicular fluid (FF) of mares.
Follicular tJuid samples (4 Ill) from individual mares were evaluated for binding to 1251_
IGF-TI as described in Materials and Methods. Lane 1-2: FF samples from large and
medium follicles of mare 1 during the follicular phase; Lane 3-8: FF samples from large,
medium and small follicles of mare 2 during the luteal phase; Lane 9-10: FF ample
from large and small follicles of mare 3 during the luteal phase. Note the los ofIGFBP-
2 and -5 in mare 1 and 2 with estrogenic follicles.
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Figure 4. Binding activity ofIGFBP-3 (Panel A), IGFBP-4 (Panel B), and IGFBP-5
(Panel C) in mare follicular FF collected from small (6-15 rnm), medium (6-25 rnm) or
large (> 25 rnm) follicles. a,b,CWithin a panel, means without a cornman superscript differ
(P < 0.05).








































Figure 5. Representative autoradiograph measuring proteolytic activity of mare
follicular fluid to recombinant human /2sT-labeled IGFBP-2 and -3. (F=follicular phase,
L=luteal phase).










































Figure 6. Representative autoraJiograph measuring proteolytic activity of mare
follicular fluid to recombinant human 125I-labeled IGFBP-5. (F=follicular phase,
L=luteal phase). Note the association of estrogenic activity in the 30 mm follicle of mare
8 with degradation of 125I_IGFBP_5.
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Figure 7. Mare follicular fluid protease activity to 12sI_IGFBP_5 as measured by the
amount of breakdown products (BDP). The 19-kDa BDP (Panel A), 16-kDa BDP (Panel
B), and 14.5-kDa BDP (Panel C). Follicles were classified as small (6-15 mm), medium
(16-25 mm) and large (> 25 mm). Interaction of size by group (P < 0.05). a,b Within a


















































ED 0.10 1.0 6.0
11..
(!) Do se of Inh ibitor (m M)
Figure 8. Inhibition of mare FF IGFBP-5 protease activity as measured by the % of
controL The serine protease inhibitors CAA. PMSF and aprotinin (Panel A). The
metalloprotease inhibitors doxycycline, EDTA and 1,1 O-Phenanthroline (Panel B).
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Figure 9. Representative autoradiograph measuring proteolytic activity of mare
follicular fluid to recombinant human 125I-labeled IGFBP-5 with protease inhibitors.
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Table 1. Simple Pierson correlation coefficients among diameter, levels of estradiol-17p
(E2), androstenedione (~), progesterone (P4), IGF-I, IGF-II, IGFBP-2, -3, -4, and -5 in
equine follicular fluid (n=92).
Follicular Fluid
IGFBP-2 IGFBP-3 IGFBP-4 IGFBP-5
Diameter -0.40** 0.18 -0.27** -0.43**
E2 -0.46** 0.01 -0.26* -0.42**
~ -0.37** 0.02 -0.20 -0.32**
P4 -0.18 -0.24* -0.20 -0.33**
IGF-I -0.73** -0.06 -0.40** -0.37**




Table 2. Simple Pierson correlation coefficients among diameter, levels of estradiol-
17~, (E2), androstenedione (~), progesterone (P4), IGF-I, IGF-II, IGFBP-2, IGFBP-3,
IGFBP-4, IGFBP-5 and 125I_IGFBP_5 proteolytic fragments in equine follicular fluid
(n=36).
125I_IGFBP_5 Fragments
J9kDa 17 kDa 14.5 kDa
Diameter 0.54** 0.53** 0.41 *
E2 0.68** 0.66** 0.52**
~ 0.35* 0.34* 0.18
P4 0.19 0.23 0.22
IGF-I 0.49** 0.52** 0.42*
IGF-II 0.45** 0.45* 0.45*
IGFBP-2 -0.53** -0.48** -0.39*
IGFBP-3 -0.20 -0.24 -0.33
IGFBP-4 -0.37* -0.29 -0.3 ]




Adashi EY, Resnick CE, Hernandez ER, Hurwitz A, Rosenfeld RG. Follicle-stimulating
hormone inhibits the constitutive release of insulin-like growth factor binding
proteins by cultured rat ovarian granulosa cells. Endocrinology 1990; 126: 1305-
1307.
Adashi EY, Resnick CE, Hurwits A, Ricciarelli E, Hernandez ER, Rosenfeld RO.
Ovarian granulosa cell-derived insulin-like growth factor binding proteins:
modulatory role of follicle-stimulating hormone. Endocrinology 1991; 128: 754-
760.
Belin F, Goudet G, Duchamp O. Gerard N. Intrafollicular concentrations of steroids and
steroidogenic enzymes in relation to follicular development in the mare. Bioi
Reprod 2000; 62: 1335-1343.
Besnard N, Pisselet C, Monniaux D, Monget P. Proteolytic activity degrading insulin-
like growth factor-hinding protein -2, -3, -4, and -5 in healthy growing and atretic
follicles in the pig ovary. BioI Reprod 1997; 56: 1050-] 058.
Besnard N, Pisselet C, Zapf J, Hornebeck W, Monniaux D, Monget P. Proteolytic
activity is involved in changes in intrafollicular insulin-like growth factor-binding
protein levels during growth and atresia of ovine ovarian follicles. Endocrinology
1996; 137: 1599-1607.
Cataldo NA, Giudice LC. Insulin-like growth factor binding protein profiles in human
ovarian follicular fluid correlate with follicular functional status. J Clin
Endocrinol Metab 1992; 74: 821-829.
Chan K, Spencer EM. General aspects of insulin-like growth factor binding proteins.
Endocrine 1997; 7: 95-97.
Chandrasekher YA, Van Dessel HJHM, Fauser BCJM, Giudice LC. Estrogen- but not
androgen-dominant human ovarian follicular fluid contains an insulin-like growth
factor binding protein-4 protease. J Clin Endocrinol Metab 1995; 80: 2734-2739.
93
94
Davenport ML, Clemmons DR, Miles MV, Camacho-Hubner C, D'Ecrole AJ,
Underwood JAH. Regulation of serum insulin-like growth factor-I (lGF-I) and
IGF binding proteins during rat pregnancy. Endocrinology 1990; 127: 1278-
1286.
Davies Sc. Holly IMP, Coulson VJ, Cotterill AM, Abdulla AF, Whittaker PG, Chard T,
Wass JAH. The presence of cation-dependent proteases for insulin-like growth
factor binding proteins does not alter the size distribution of insulin-like growth
factors in pregnancy. Clin Endocrinol (Oxf) 1991; 34: 501-506.
De La Sota RL, Simmen FA, Diaz T, Thatcher WW. Insulin-like growth factor system in
bovine first-wave dominant and subordinate follicles. Bioi Reprod 1996; 55: 803-
812.
Echternkamp SE, Howard HJ, Roberts AJ, Grizzle J, Wise T. Relationship among
concentrations of steroids, insulin-like growth factor-I, and insulin-like growth
factor binding proteins in ovarian follicular fluid of beef cattle. BioI Reprod
1994a; 5 1: 971-981.
Echternkamp SE, Spicer LJ, Gregory KE, Canning SF, Hammond JM. Concentrations of
insulin-like growth factor-I in blood and ovarian follicular fluid of cattle selected
for twins. BioI Reprod 1990; 43: 8-14.
Echternkamp SE, Spicer LJ, Klindt J, Vernon RK, Yen JT, Buonomo Fe.
Administration of porcine somatotropin by a sustained-release implant: Effects on
follicular growth, concentrations of steroids and insulin-like growth factor-I, and
insulin-like growth factor binding protein activity in follicular fluid of control,
lean, and obese gilts. J Anim Sci 1994b; 72: 2431-2440.
Fay lE, Douglas RH. Changes in thecal and granulosa cell LH and FSH receptor content
associated with follicular fluid and peripheral plasma gonadotropin and steroid
hormone concentrations in preovulatory follicles of mares. 1 Reprod Fert Suppl
1987; 35: 169-181.
Fielder PJ, Pham H, Adashi EY, Rosenfeld RG. Insulin-like growth factors (lGFs) block
FSH-induccd proteolysis ofIGF-binding protcin-5 (BP-5) in cultured rat
granulosa cells. Endocrinology 1993; 133: 415-418.
Funston RN, Seidel GE Jr, Klindt 1, Roberts AJ. Insulin-like growth factor-binding
proteins in bovine serum and follicular fluid before and after preovulatory surge
of luteinizing hormone. Bioi Reprod 1996; 55: 1390-1396.
Gastal EL, Gastal MO, Bergfelt DR, Ginther 01. Role of diameter differences among




Gerard N, Monget P. Intrafollicular insulin-like growth factor-binding protein levels in
equine ovarian follicles during preovulatory maturation and regression. BioI
Reprod 1998; 58: 1508-1514.
Ginther OJ, Pierson RA. Regular and irregular characteristics of ovulation and the
interovulatory interval in mares. Eq Vet Sci 1989; 9: 4-12.
Giudice LC. Insulin-like growth factors and ovarian follicular development. Endocr Rev
1992; 13: 641-669.
Giudice LC, Farrell EM, Pham H, Rosenfeld RG. Identification of insulin-like growth
factor-binding protein-3 (IGFBP-3) and IGFBP-3 in human follicular fluid. J Clin
Endocrino! Metab 1990; 71: 1330-1338.
Grimes RW, Guthrie HD, Hammond J. Insulin-like growth factor binding protein-2 and -
3 arc correlated with atresia and preovulatory maturation in the porcine ovary.
Endocrinology 1994; 135: 1996-2000.
Henderson KM, Franchimont P. Regulation of inhibin production of bovine ovarian cells
in vitro. J Reprod Fertil 1981; 63: 431-442.
Hossenlopp P, Segovia B, Lassarre C, Roghani M, Bredon M, Binoux M. Evidence of
enzymatic degradation of insulin-like growth factor-binding proteins in the 150K
complex during pregnancy. J Clin Endocrinol Metab 1990; 71: 797-805.
Howard HJ, Ford J1. Relationships among concentrations of steroids, inhibin, insulin-
like growth factor-I (IGF-I) and IGF-binding proteins during follicular
development in weaned sows. BioI Reprod 1992; 47: 193-201.
Hwa V. Oh Y, Rosenfeld RG. The insulin-like growth factor-binding protein (lGFBP)
superfamily. Endocr Rev 1999; 20: 761-787.
Ireland JJ, Roche JF. Development of antral follicles in cattle after prostaglandin-
induced luteolysis: changes in serum honnones, steroids in follicular fluid, and
gonadotropin receptors. Endocri.nology 1982; Ill: 2077-2086.
Kenney RM, Condon W, Ganjam VK, Channing C. Morphological and biochemical
correlates of equine ovarian follicles as a function of their state of viability or
atresia. J Reprod Fert Supp1 27 1979; 163-171.
Kruip TH. AM, Dieleman SJ, Moor RM. Steroid production by bovine follicles in vitro:
influence of size, stage of cycle and culture system. Ann Bioi Anim Biochem
Biophys 1979; 19: 1537.
......
96
Langhout DJ, Spicer LJ, Geisert RD. Development ofa culture system for bovine
granulosa cells: effects of growth hormone, estradiol, and gonadotropins on cell
proliferation, steroidogenesis, and protein synthesis. J Anim Sci 1991; 69: 332}-
3334.
Liu X-J, Malkowski M, Guo Y, Erickson GF, Shimasaki S, Ling N. Development of
specific antibodies to rat insulin-like growth factor-binding proteins (IGFBP-2 to -
6): analysis of IGFBP production by rat granulosa cells. Endocrinology 1993;
132: 1176-1183.
Mazerbourg S, Zapf J, Bar RS, Brigstock DR, Lalou C, Binoux M, Monget P. Insulin-
like growth factor binding protein-4 proteolytic degradation in ovine preovulatory
follicles: studies of underlying mechanisms. Endocrinology 1999; 140: 4175-
41R4.
Mazerbourg S, Zapf J, Bar RS, Brigstock DR, Monget P. Insulin-like growth factor
(IGF)-binding protein-4 proteolytic degradation in bovine, equine, and porcine
preovulatory follicles: regulation by IGFs and heparin-binding domain-containing
peptides. BioI Reprod 2000; 63: 390-400.
Meinecke B, Gips, Meinecke-Tillmann S. Progestagen, androgen and oestrogen levels in
plasma and ovarian follicular fluid during the oestrus cycle of the mare. Anim
Reprod Sci 1987; 12: 255-265.
Mondschein JS, Etherton TD, Hammond JM. Characterization of insulin-like growth
factor-binding proteins of porcine ovarian follicular fluid. Bioi Reprod 1991; 44:
315-320.
Monget P, Besnard N, Huet C, Pisselet C, Monniaux D. Insulin-like growth factor-
binding proteins and ovarian folliculogenesis. Horm Res 1996; 45: 211-217.
Monget P, Monniaux D, Pisselet C, Durand P. Changes in insulin-like growth factor-I
(lGF-I), IGF-II, and their binding proteins during growth and atresia of ovine
ovarian follicles. Endocrinology 1993; 132: 1438-1446.
Nakatani A, Shimasaki S, Erickson GF, Ling N. Tissue-specific expression of four
insulin-like growth factor-binding proteins (I, 2, 3, and 4) in the rat ovary.
Endocrinology 1991; 129: 1521-1529.
Prosser CG, McLaren RD. Insulin-like growth factor binding proteins of equine serum.
Biochem Biophys Res Comm 1992; 189: 1255-1260.
Rajarm S, Baylink DJ, Mohan S. Insulin-like growth factor-binding proteins in serum




San Roman GA, Magoffin DA. Insulin-like growth factor-binding proteins in healthy
and atretic foUicles during natural menstrual cycles. J Clin Endocrinol & Metab
1993; 76: 625-632.
SAS. 1988. SAS/STAT User's Guide. 6th eOO; SAS Institute Inc., Cary, NC, pp. 549-
640.
Simpson RB, Chase, Jr. CC, Spicer LJ, Carron JA, Hammond AC, Welsh Jr. TH. Effect
of exogenous estradiol on plasma concentrations of somatotropin, insulin-like
growth factor-I, insulin-like growth factor binding protein activity, and
metabolites in ovariectomized Angus and Brahman cows. Domest Anim
Endocrinol1997; 14: 367-380.
Spicer LJ, Chamberlain CS. Insulin-like growth factor binding protein-3: its biological
effect on bovine granulosa cells. Domest Anim Endocrinol 1999; 16: 19-29.
Spicer LJ, Chamberlain CS. Proteolytic activity degrading insulin-like growth factor-
binding protein (IGFBP)-4 and -5 but not IGFBP-2 and -3 in preovulatory bovine
follicles. BioI Reprod 2000; 62: 123.
Spicer LJ, Echternkamp SE. The ovarian insulin and insulin-like growth factor system
with an emphasis on domestic animals. Domest Anim Endocrino11995; 12: 223-
245.
Spicer LJ, Echternkamp SE, Hammond 1M. Relationship between concentrations of
immunoreactive insulin-like growth factor-I in follicular fluid and various
biochemical markers of differentiation in bovine antral follicles. Bioi Reprod
1988; 39: 563-580.
Spicer LJ, Echternkamp SE, Wong EA, Hamilton DT, Vernon RK. Serum hormones,
follicular fluid steroids, insulin-like growth factors and their binding proteins, and
ovarian IGF mRNA in sheep with different ovulation rates. J Anim Sci 1995; 73:
1152-1163.
Spicer LJ, Enright WJ. Concentrations of insulin-like growth factor I and steroids in
follicular fluid of preovulatory bovine ovarian follicles: effect of daily injections
of a growth hormone-releasing factor analog and (or) thyrotropin-releasing
hormone. J Anim Sci 1991; 69:1133-1139.
Spicer LJ, Tucker KE, Henderson KA, Duby RT. Concentrations of insulin-like growth
factor-I in follicular fluid and blood plasma of mares during early and late estrus.
Anim Reprod Sci 1991; 25: 57-65.
Stanko RL, Cohick WS, Shaw DW, Harvey RW, Clemmons DR, Whitacre MD,
Armstrong JD. Effect of somatotropin and/or equine chorionic gonadotropin on
98
serum and follicular insulin-like growth factor I and insulin-like growth factor
binding proteins in cattle. BioI Reprod 1994; 50: 290-300.
Stewart RE, Spicer LJ, Hamilton TD, Keefer BE, Dawson LJ, Morgan GL, Echtemkamp
SE. Levels of insulin-like growth factor (lGF) binding proteins, luteinizing
honnone and IGF-I receptors, and steroids in dominant follicles during the first
follicular wave in cattle exhibiting regular estrous cycles. Endocrinology 1996;
137: 2842-2850.
Ui M, Shimonaka M, Shimasaki S, Ling NC. An insulin-like growth factor-binding
protein in ovarian follicular fluid blocks follicle-stimulating hormone-stimulated
steroid production by ovarian granulosa cells. Endocrinology; 1989; 125: 912-
916.
Watson ED, Hinrichs K. Changes in the concentrations of steroids and prostaglandin F in
preovulatory follicles of the mare after administration of hCG. J Reprod Fen
1988; 84: 557-561.
Westlund B, Dahms NM, Kornfeld S. The bovine mannose 6-phosphate of the insulin-
like growth factor II receptor: localization of mannose 6-phosphate binding sites




It is thought that follicular steroidogenesis and mitogenesis are stimulated by an
increase in bioavailable IGF that may occur through degradation ofIGFBPs. In this
study, low amounts of IGFBP-2, -4 and -5 were detected in large, estrogenic follicles
when compared to small or medium follicles. As well, follicular fluid IGF-I
concentrations were greater in large follicles versus small and medium follicles. IGF-ll
concentrations in FF were greater in follicular phase follicles than in luteal phase
follicles. E2 and ~ concentrations in FF were greater in large than in small or medium
follicles and follicular phase mares had greater E2 in large follicles than luteal phase
mares. Lack of follicular fluid proteolysis of recombinant human 125I-labeled IGFBP-2
and -3 demonstrated that loss of IGFBP-2 was possibly through a decrease in gene
expression in large dominant follicles. 1251-labeled IGFBP-5 was cleaved by FF from
large follicles collected during the follicular phase, but not the luteal phase. The IGFBP-
5 proteolysis was positively correlated with follicular fluid E2 levels. Based on results of
the present study, low amounts of IGFBP-5 in follicular fluid are likely the result of
enzyme degradation. This was the first evaluation on proteolysis of IGFBP-S in mare FF.
Increase in steroidogenesis of large follicles may be due to an increase in the bioavailable
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